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Abstract  
 
Large amounts of biological data are continuously generated nowadays, thanks to the 
advancements of high-throughput experimental techniques. Mining valuable 
knowledge from such data still motivates the design of suitable computational 
methods, to complement the experimental work which is often bound by 
considerable time and cost requirements. Protein complexes, or groups of interacting 
proteins, are key players in most cellular events. The identification of complexes not 
only allows to better understand normal biological processes but also to uncover 
disease-triggering malfunctions. Ultimately, findings in this research branch can 
highly enhance the design of effective medical treatments. The aim of this research is 
to detect protein complexes in protein-protein interaction networks and to associate 
the detected entities to diseases. The work is divided into three main objectives: first, 
develop a suitable method for the identification of protein complexes in static 
interaction networks; second, model the dynamic aspect of protein interaction 
networks and detect complexes accordingly; and third, design a learning model to 
link proteins, and subsequently protein complexes, to diseases. In response to these 
objectives, we present, ProRank+, a novel complex-detection approach based on a 
ranking algorithm and a merging procedure. Then, we introduce DyCluster, which 
uses gene expression data, to model the dynamics of the interaction networks, and we 
adapt the detection algorithm accordingly. Finally, we integrate network topology 
attributes and several biological features of proteins to form a classification model 
for gene-disease association. The reliability of the proposed methods is supported by 
various experimental studies conducted to compare them with existing approaches. 
ProRank+ detects more protein complexes than other state-of-the-art methods. 
DyCluster goes a step further and achieves a better performance than similar 
techniques. Then, our learning model shows that combining topological and 
biological features can greatly enhance the gene-disease association process. Finally, 
we present a comprehensive case study of breast cancer in which we pinpoint disease 
genes using our learning model; subsequently, we detect favorable groupings of 
those genes in a protein interaction network using the ProRank+ algorithm. 
 
viii 
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عن المركبات البروتينية وربط الجينات  كشفدراسة الشبكات البيولوجية بهدف ال
 بالأمراض
 صالملخ
يتم توليد كميات كبيرة من البيانات البيولوجية في الوقت الحاضر وذلك بفضل تقدّم 
قيّمة من هذه البيانات يحفز ما زال استخراج معلومات  التقنيات التجريبية ذات الإنتاجية العالية.
تصميم طرق حاسوبية مناسبة، لاستكمال العمل التجريبي المرتهن غالبا ًبوقت طويل ومتطلبات 
الكلفة. المركبات البروتينية، أو مجموعات البروتينات المتفاعلة هي لاعب أساسّي في معظم 
جية العادية بشكل أفضل فحسب الأحداث الخلوية. لا يسمح تحديد المركبات بفهم العمليات البيولو
في النهاية، تستطيع نتائج فرع البحث هذا  بل أيضا ًبالكشف عن الاختلالات المسببة للأمراض.
هدف هذا البحث الكشف عن المركبات  تحسين تصميم العلاجات الطبية الفعالة إلى حد كبير.
 نات المكتشفة بالأمراض.البروتينية في شبكات تفاعل البروتينات مع بعضها البعض وربط الكيا
أهداف رئيسية: أولا،ً تطوير طريقة مناسبة لتحديد المركبات البروتينية  3العمل مقّسم إلى  إن
ثانيا،ً صياغة الجانب الديناميكي لشبكات تفاعل البروتينات واستبيان  في شبكات تفاعل ثابتة.
البروتينات وبالتالي المركبات  المركبات وفقا ً لذلك. ثالثا،ً تصميم نموذج تعلّم حاسوبي لربط
، وهو أسلوب جديد في تحديد برورانك+ البروتينية، بالأمراض. رداً على هذه الأهداف، نقدّم
، الذي دايكلستر المركبات مبنّي على خوارزمية لتصنيف المركبات وترتيبها ودمجها. ثم ندخل
ونكيّف خوارزمية الكشف وفقا ً يستخدم بيانات التعبير الجيني لصياغة ديناميات شبكات التفاعل
لذلك. أخيرا،ً ندمج الصفات الطوبولوجية لشبكة البروتينات في سمات البروتينات البيولوجية 
مصداقية الطرق المقترحة مدعومة بدراسات  لتشكيل نموذج تصنيف لربط الجينات بالأمراض.
عن مركبات بروتينية برورانك+ تجريبية متنوعة أجريت لمقارنتها مع أساليب قائمة. يكشف 
خطوة أبعد ويحقق أداًء أفضل من أداء دايكلستر  أكثر من أّي أساليب متطورة أخرى. يذهب
تقنيات مشابهة. ثم يظهر نموذج التعلّم الخاص بنا أن الجمع بين السمات الطوبولوجية والسمات 
يرا،ً نقدّم دراسة البيولوجية يستطيع أن يحّسن إلى حد كبير عملية ربط الجينات بالأمراض. أخ
شاملة لحالة سرطان الثدي نحدد فيها جينات المرض مستخدمين نموذج التعلّم الخاص بنا. من ثم 
 x
 
نحدد التجمعات المناسبة لتلك الجينات في شبكة تفاعل البروتينات مستخدمين خوارزومية 
 .برورانك+
 التعبير البروتينية، المركبات البعض، بعضها مع البروتينات تفاعل :مفاهيم البحث الرئيسية
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Chapter 1: Introduction 
 
1.1 Scope 
From metabolism, signal transduction, transport, cellular organization to most 
biological processes, proteins are the key players. Their interconnections shape 
interaction networks which define highly-organized cellular systems (1000 Genomes 
Project Consortium, 2010). The association of a gene or a complex to a certain 
biological function broadens our perception of how this function occurs and it 
consequently allows us to uncover the malfunctions that trigger various diseases. For 
instance, in terms of a normal phenomenon, happiness can be psychologically 
defined as “the experience of joy, contentment, or positive well-being, combined 
with a sense that one’s life is good, meaningful, and worthwhile” (Lyubomirsky, 
2008). Philosophically, according to Aristotle, “Happiness depends upon ourselves”. 
Genetically, legitimate questions are asked: How far does happiness really depend on 
“ourselves”? Do genes, the shaping elements of “ourselves”, contribute to our 
happiness? In fact, genetics are linked to individual life satisfaction and particularly 
to happiness: long and more efficient alleles of the serotonin transporter gene 5-
HTTLPR and self-reported life satisfaction are positively associated (De Neve, 
Christakis, Fowler, & Frey, 2012). In view of that, a recent study (Oswald & Proto, 
2013) measures the genetic distance among countries’ populations and finds that it is 
highly correlated with international well-being differences. On the other hand, in 
terms of identifying disease-related genes, in ancient history, cancers were blamed on 
the gods (The History of Cancer, 2015). Then, through the middle ages, it was 
associated to imbalances in the body. Various theories were proposed later ranging 
from the lymph theory in the 1700s to the trauma theory and the infectious disease 
2 
 
theory in the 17th and the 18th centuries. Accumulated knowledge in genetics 
throughout the following years allowed more understanding of the disease. In 2014, 
more than 100 chemical, physical and biological substances were associated by the 
World Health Organization to cancer (World Health Organization IARC, 2014). In 
the same year, breast cancer was listed as the highest occurring cancer type in 
women worldwide (World Health Organization, 2014). The earlier association of the 
BRCA1 gene to breast cancer (Miki et al., 1994) not only accelerated the design of 
more efficacious treatments but also allowed the discovery of many key genes and 
complexes in other cancer types and complex diseases.  
Looking at the bigger picture, every genetic finding can be viewed as a 
puzzle piece that contributes to our comprehension of various molecular functions as 
well as different disorders. Ultimately, the more we know, the more we are able to 
improve medical treatments. 
1.2 Background 
The deoxyribonucleic acid (DNA) is considered the cell’s “master molecule” 
thanks to its essential functional properties (Lodish et al., 2013). It has a double-helix 
structure composed by two helical strands coiled around a common axis (Watson & 
Crick, Molecular structure of nucleic acids, 1953). This structure allows transferring 
genetic characteristics among successive generations and is thus crucial to heredity. 
The DNA strands consist of four types of nucleotides: adenine (A), thymine (T), 
cytosine (C) and guanine (G). They are arranged in such a way that A on one strand 
is matched with T on the other strand and likewise, C is matched with G. The linear 
order of nucleotides along each strand defines the genetic information carried by 
DNA. The informative segments of DNA are divided into functional units called 
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genes which typically consist of 5,000 to 100,000 nucleotides. Many genes are 
responsible for making proteins, the primary molecules defining cellular structure 
and activities. The conversion of DNA into proteins is divided into two processes as 
presented in Figure 1. The first process is transcription by which the coding portion 
of a gene is copied into a single-stranded ribonucleic acid (RNA) version of DNA. A 
large enzyme called RNA polymerase uses DNA as a template and catalyzes the 
linkage of nucleotides into RNA chain. In eukaryotic cells, RNA is transformed into 
a smaller messenger RNA (mRNA) molecule which moves to the cytoplasm region 
of the cell. This is where the second process, known as translation, takes place. A 
very complex molecular machine called ribosome and composed of both RNA and 
Figure 1: The multi-process conversion of DNA into protein (Lodish et 
al., 2013). 
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Figure 2: Protein structure and function (Lodish et al., 2013). 
protein comes into play. The ribosome assembles amino acids to form proteins 
exactly as inferred by the mRNA sequence. Proteins consist of linear chains in which 
20 different amino acids can be combined. Once a chain is created, it folds to form a 
three-dimensional structure which determines its distinctive function, as shown in 
Figure 2. The linear amino acid sequence of a protein (primary structure) folds into 
helices (secondary structure) that pack into globular domains (tertiary structure). 
Some proteins self-associate into complexes (quaternary structure) which comprise 
tens to hundreds subunits (supramolecular assemblies). Proteins can exhibit various 
functions including regulation, structure, movement, catalysis, transport and 
signaling. All those functions are subject to proper protein folding. The types and 
amounts of mRNA molecules existing in a cell determine its function. Accordingly, 
the course of protein formation through transcription and translation critically defines 
the functions of cells (O'Connor, Adams, & Fairman, 2010). The regulation of those 
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Figure 3: The structural levels of proteins 
(Wikimedia Commons, 2008). 
processes allows cells to respond to environmental variations. In the same context, 
we note here that genes which exhibit similar expression patterns across various 
environmental conditions most likely interact (Baldi & Hatfield, 2002). 
 
 
 
 
6 
 
Figure 3 visualizes the four structure levels of a protein, from amino acid 
sequence to protein complex. Mutations are errors that occur during DNA 
replication. It alters the nucleotide sequence by changing its order, deleting or 
inserting an element, or even inverting it. This can cause the abnormal generation of 
proteins and can lead to inherited diseases if not controlled properly. For example, 
the sickle cell disease is caused by a single mutation of the hemoglobin gene by 
which the 17th nucleotide is changed from T to A (Rees, Williams, & Gladwin, 
2010). In view of that, identifying disease-causing mutations and subsequently, 
disease-related genes, protein and protein complexes is indeed a crucial task towards 
understanding various disorders and finding suitable ways to possibly avoid or treat 
them. 
1.3 Motivation and Problem Statement 
Biological functions are often acquired through collaborations of interacting 
protein groups referred to as protein complexes (Gavin et al., 2006). High-throughput 
experimental techniques designed to study protein complexes, such as yeast two-
hybrid (Y2H) (Fields & Song, 1989) and tandem affinity purification (TAP-MS) 
(Collins & Choudhary, 2008) approaches, are generally time-consuming and costly. 
Moreover, they are susceptible to high error rates (Marto, 2009). In view of that, 
various computational methods are developed to complement and reduce the efforts 
required for biological explorations. Ideally, looking at protein-protein interaction 
(PPI) data, a reliable computational approach can identify proteins and subsequently 
protein complexes possibly engaged in certain functions or phenotypes, for further 
experimental examinations. It is believed that the more enrichment with biological 
information is added to interaction networks and complex-detection algorithms, the 
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(a) 
(b) 
Figure 4: An example of a protein complex. (a) A graph 
representation in which nodes and edges represent 
protein and their interactions, respectively. (b) The 
biological assembly of the complex. 
better is the overall quality of the results. In a computational context, a PPI dataset is 
usually modeled as a single graph in which vertices and edges represent the proteins 
and their interconnections, respectively. An example of a protein complex is shown 
in Figure 4 in terms of graph and structural representations based on the work by 
(Newman, Brändén, & Jones, 1993) and visualized at the Protein Data Bank (Berman 
et al., 2000).  
Given a PPI dataset, the goal is to develop a suitable computational approach 
that can identify the corresponding protein complexes and subsequently associate the 
detected entities to diseases. In this direction, several challenges need to be 
addressed. First, experimentally-generated datasets are usually large. For instance, in 
the case of human PPIs, the June 2015 release of the BioGRID repository (Stark et 
al., 2006) contains 186744 non-redundant interactions among 19415 unique proteins. 
As a result, scalable and efficient methods are required for their analysis. In addition, 
PPI data may contain false positive (spuriously-detected) and false negative 
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(missing) interactions. Consequently, suitable data cleaning techniques have to be 
applied prior to analysis in order to ensure the reliability of the results. Moreover, 
protein interactions do not occur simultaneously. They are subject to temporal, 
spatial and contextual conditions (Macropol, Can, & Singh, 2009). Accordingly, the 
comprehensive network representation of a PPI dataset ought to take the dynamic 
nature of interactions into consideration. These main challenges, among others, 
constitute the focus points based on which our methodology is designed and 
developed.  
1.4 Research Objectives and Proposed Solutions 
The goal of this dissertation is to develop a suitable approach for the 
identification and association of proteins and protein complexes to diseases. In this 
direction, the work is divided into three main objectives: 
1- Detecting protein complexes in PPI networks. 
2- Modeling the dynamic aspect of PPI networks and detecting protein 
complexes accordingly. 
3- Developing a learning model to classify genes as disease-related or 
not. 
To begin, we introduce ProRank+ (Hanna & Zaki, 2014), a protein-complex 
detection method based on a ranking algorithm which sorts proteins according to 
their importance in the PPI network; and a merging procedure which refines the 
detected complexes in terms of their members. When compared to several state-of-
the-art approaches, ProRank+ is able to detect more protein complexes with higher 
quality scores. 
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Since protein interaction networks are dynamic in nature (Levy & Pereira-
Leal, 2008), our second objective is to model the dynamic aspect of PPI networks 
and to tune ProRank+ accordingly. Recent experimental tools, such as ChIP-chip 
(Kim & Ren, 2006) and ChIP-seq (Johnson, Mortazavi, Myers, & Wold, 2007), can 
provide temporal, spatial and contextual information across which PPIs occur. 
Consequently, advances in computational approaches developed to analyze PPI 
networks ought to relate to such diversity of information which is currently available. 
Gene expression datasets consist of quantitative measurements of genes in cellular 
compartments across different conditions (Lovén et al., 2012). Genome-wide 
expression levels can now be studied (Secrier & Schneider, 2013). Genes with 
correlated expressions across subsets of conditions most likely interact (Baldi & 
Hatfield, 2002). As a result, the integration of gene expression data with PPI 
information can potentially reveal the processes which underline the formation of 
protein complexes. In this direction, we present DyCluster, a framework to model the 
dynamic aspect of protein interaction networks by incorporating gene expression 
data, through biclustering techniques (Busygin, Prokopyev, & Pardalos, 2008), prior 
to applying complex-detection algorithms. The experimental studies, including 
biological applications, show that DyCluster leads to high numbers of correctly 
detected complexes with better evaluation scores. 
 The last objective consists of designing a suitable approach for gene-disease 
association. We propose a learning model which integrates PPI network topology 
features and biological information collected from various sources. A learning 
model, here classification model, given training data (data objects whose class label 
is known), consists of a set of functions that can describe and distinguish data 
classes. Such model can then be used to predict the class of objects whose class label 
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is unknown. Given a list of genes, the goal is to maximize the contrast between 
disease and non-disease classes. Accordingly, we study the topology of the 
corresponding PPI network to find distinctive positioning of genes in interaction 
networks. Then, we combine those features with biological data from various sources 
to uncover potential similarities which characterize each class. The experimental 
work strongly favors our approach. 
1.5 Dissertation Outline 
The dissertation is organized as follows. In chapter 2, we survey and discuss 
state-of-the-art methods related to our research objectives. Chapter 3 introduces our 
method for the detection of protein complexes in PPI networks. In chapter 4, we 
present our approach to model dynamic protein interaction networks and 
subsequently detect complexes. Chapter 5 includes our solution for gene-disease 
association. A comprehensive case study of the breast cancer disease is presented in 
chapter 6. Finally, we conclude the dissertation in chapter 7. 
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Chapter 2: Related Work 
 
This chapter surveys the state-of-the-art approaches related to our research 
objectives. Computational methods developed for the detection of protein complexes 
in PPI networks are reviewed in section 2.1. Various ways to model the dynamic 
aspect of PPI networks and detect protein complexes accordingly are presented in 
section 2.2. Gene-disease association approaches are discussed in section 2.3. Lastly, 
the drawbacks of previous approaches that we seek to overcome in our work are 
summarized in section 2.4. 
2.1 Detecting Protein Complexes in Protein-Protein Interaction Networks 
In a computational setting, it is generally assumed that protein complexes 
correspond to dense subgraphs in PPI networks. We hereafter highlight state-of-the-
art methods for the detection of complexes in protein interaction networks. The 
Markov Clustering algorithm (MCL) (Van Dongen, 2001) looks for cluster structures 
in protein interaction networks using random walks. The search is based on 
alternations between two main operators:  expansion which is given by taking the 
power of a stochastic matrix using matrix squaring; and inflation which corresponds 
to taking the Hadamard power of a matrix, i.e. entry-wise, followed by a scaling step, 
to generate a stochastic matrix. The algorithm deterministically calculates the 
probabilities of random walks in the network and transforms one set of probabilities 
into another based on the expansion and inflation operators. The Molecular Complex 
Detection (MCODE) algorithm (Bader & Hogue, 2003) identifies complexes as 
dense regions grown from highly-weighted vertices. A vertex is weighted by 
checking the highest k-core in its neighbourhood, i.e. the central most densely 
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connected subgraph of minimal degree k. MCODE then seeds complexes with 
proteins, considered by their decreasing weights, and include only vertices of weights 
above a given threshold, at each time. The clustering based on maximal cliques 
(CMC) method (Liu, Wong, & Chua, 2009) starts by using an iterative scoring 
scheme to assign weights to protein interactions.  Lower scores correspond to less 
reliable interactions in order to reduce their impact in the detection process. All 
maximal cliques are generated from the PPI network and then, they are ranked based 
on their weighted density. Finally, highly overlapping cliques are merged or 
removed. The Affinity Propagation (AP) algorithm (Frey & Dueck, 2007) uses a 
distance matrix to propagate messages between nodes until a high-quality set of 
“exemplars” and corresponding clusters are gradually generated. ClusterONE 
(Nepusz, Yu, & Paccanaro, 2012) identifies protein complexes through clustering 
with overlapping neighborhood expansion. A cohesiveness measure is introduced to 
reflect the notion by which a protein complex is viewed as an entity that is well-
separated from the rest of the network and whose members have reliable 
interconnections. Proteins are considered by their descending order of degrees and a 
greedy algorithm is applied to generate complexes by joining proteins which are not 
yet added to any complex. Next, groupings with high overlaps are merged and 
complexes with less than three proteins or with low density are discarded. The 
Restricted Neighborhood Search Clustering (RNSC) algorithm, presented in (King, 
Pržulj, & Jurisica, 2004) and (Pržulj, Wigle, & Jurisica, 2004), is a cost-based local 
search algorithm that uses the tabu metaheuristic. It seeks to partition proteins into 
highly-interconnected subsets. The method starts with a random clustering and then, 
moves nodes from one group to another to improve clustering cost. The RRW 
algorithm (Macropol, Can, & Singh, 2009) exploits the global structure of a PPI 
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network using repeated random walks. It moves from one node to another based on 
the probabilities of the connective edges. CFinder (Adamcsek et al., 2006) finds 
overlapping and fully-connected complexes based on the clique percolation method. 
The GIBA tool (Moschopoulos, Pavlopoulos, Schneider, Likothanassis, & Kossida, 
2009) clusters the whole network and then, filters the generated clusters in order to 
only keep the important ones. 
Although these state-of-the-art methods offer good solutions to the 
considered problem, most of them are bound by the assumption that protein 
complexes only correspond to dense subgraphs in protein interaction networks. As a 
result, they cannot identify complexes with few members and/or few interactions. 
That is an important drawback to overcome since for instance, among the 313 protein 
complexes included in the MIPS catalogue (Mewes et al., 2006), 104 complexes 
consist of 2 or 3 proteins (approximately 33%).  ProRank, introduced in (Zaki, 
Berengueres, & Efimov, 2012a) and (Zaki, Berengueres, & Efimov, 2012b) is a 
recent complex-detection method which is not restrained by this density supposition. 
It is mainly based on a protein ranking algorithm inspired by Google’s PageRank 
algorithm discussed in (Brin & Page, 1998), (Bryan & Leise, 2006), (Ishii & Tempo, 
2010) and (Langville & Meyer, 2011). As PageRank sorts web pages according to 
their level of importance, ProRank applies the same analogy to rank proteins in PPI 
networks, and subsequently, to identify the “essential” ones which most-likely have 
central roles in cellular functions. Those proteins are the starting point based on 
which the detected complexes are formed. In addition, the pairwise similarities of the 
proteins are computed under the assumption that proteins belonging to the same 
complex share evolutionary relationships (Kuang, Weston, Noble, & Leslie, 2005). 
In view of the notable performance of ProRank when compared to previous 
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Figure 5: Examples of bridge, fjord and shore proteins in PPI networks. 
approaches, the algorithm is the keystone of our approach introduced hereafter. Five 
main steps delineate the ProRank algorithm (Zaki, Berengueres, & Efimov, 2012a): 
1- Pruning: PPI datasets are usually noisy; they have high false-positive and 
false-negative rates (Reguly et al., 2006). Accordingly, the first step 
consists of removing unreliable interactions which could negatively affect 
the detection process. That is done using the AdjustCD method introduced 
in (Chua, Sung, & Wong, 2006) and (Chua, Ning, Sung, Leong, & Wong, 
2008); a weighting scheme that iteratively calculates the reliability of 
protein interactions based on the topology of the network and then discards 
the interactions with scores less than a specified threshold. 
2- Filtering: based on the protein interaction network, three types of noisy 
proteins are identified: bridge proteins which have a disconnected 
subgraph of neighbors; fjord proteins whose neighbors have a small 
number of interactions among each other; and shore proteins which have at 
least one neighbor with significantly few interactions with other proteins. 
Accordingly, the network vertices are examined for possible memberships 
in these types. Figure 5 illustrates examples of the three described 
categories. 
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3- Protein Similarity Calculating: proteins belonging to the same complex are 
expected to have evolutionary relationships (Kuang, Weston, Noble, & 
Leslie, 2005). Therefore, the similarity scores among all the proteins in the 
PPI network are calculated using pairwise alignment. 
4- Protein Ranking: in analogy with the PageRank algorithm, a ranking 
algorithm is applied to order the proteins by their importance in the 
interaction network.  
Given 𝑛 interacting proteins, we represent their interaction network by a 
graph 𝐺 = (𝑉, 𝐸) where 𝑉 = 1, 2, … , 𝑛 is the set of nodes (proteins) and E 
the set of edges (interactions) among those proteins and (𝑖, 𝑗) ∈ 𝐸 if 
protein 𝑖 interacts with protein 𝑗. The goal of the ranking algorithm is to 
order proteins by their importance in the network. Accordingly, the 
importance measure 𝑥𝑖 of protein 𝑖 is a real number such that 𝑥𝑖 ∈ [0,1] 
and 𝑥𝑖 > 𝑥𝑗  means that protein 𝑖 is more important than protein 𝑗. The 
value of a protein is given by the sum of contributions of all proteins 
interacting with it. The importance of protein 𝑖 is based on the following 
equation: 
 𝑥𝑖 = ∑ 𝑆𝑖,𝑗
∗
𝑗∈𝜏𝑖
. 𝑛𝑗 (1) 
where 𝜏𝑖 ≔ {𝑗: (𝑗, 𝑖)𝜖𝐸} is the index set of the proteins interacting with 𝑖, 
𝑛𝑗  is the number of outgoing links from node 𝑗 and 𝑆
∗is the normalized 
similarity matrix computed in the Protein Similarity Calculating step. The 
total of all values is normalized i.e. ∑ 𝑥𝑖 = 1
𝑛
𝑖=1 . Let the values of 𝑥 be in 
the vector form where 𝑥 ∈ [1,0]𝑛. The PageRank algorithm can thus be 
rewritten as: 
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 𝑥 = 𝑆∗𝑥, 𝑥 ∈ [1,0]𝑛 and  ∑ 𝑥𝑖 = 1
𝑛
𝑖=1  (2) 
 
Note that the vector x is a nonnegative eigenvector corresponding to the 
eigenvalue 1 of the nonnegative matrix 𝑆∗. Nonetheless, for this 
eigenvector to exist and to be unique, it is essential that the PPI network is 
strongly connected. To find the eigenvector corresponding to the 
eigenvalue 1, a modified version of the values is defined as follows. Let 𝑚 
be a parameter such that𝑚 ∈ (0,1), and let the modified interaction matrix 
𝑀 ∈ ℜ𝑛×𝑛 be given by: 
 𝑀 ≔ (1 − 𝑚)𝑆∗ +
𝑚
𝑛
𝑙 (3) 
where 𝑙 is an 𝑛 × 𝑛 matrix with all entries equal to 1. A typical value of 𝑚 
is 0.15. 𝑀 is a positive stochastic matrix. Thus, according to Perron 
theorem 33, this matrix is primitive. Particularly, |𝜆| = 1is the unique 
maximum eigenvalue. Therefore, we apply the following formula to find 
corresponding eigenvector 𝑥: 
 𝑥(𝑘 + 1) = 𝑀𝑥(𝑘) = (1 − 𝑚)𝑆∗𝑥(𝑘) +
𝑚
𝑛
𝑙 (4) 
where 𝑥(𝑘) ∈ ℜ𝑛×1 and the initial vector 𝑥(0) ∈ ℜ𝑛×1 is a probability 
vector. Expanding on the convergence rate of this scheme, let 𝜆1(𝑀) and 
𝜆2(𝑀) be the largest and the second largest eigenvalues of 𝑀 in 
magnitude. Then, by the power method applied to 𝑀, the asymptotic rate 
of convergence is exponential and depends on the ratio 
|𝜆2(𝑀) 𝜆1(𝑀)⁄ |.Since 𝑀 is a positive stochastic matrix, we have 𝜆1(𝑀) =
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1 and 𝜆2(𝑀) < 1. Therefore, the structure of the link matrix 𝑀 leads us to 
the bound: 
 |𝜆2(𝑀)| ≤ 1 − 𝑚 (5) 
5- Complex Detection: the essential proteins are the ones which do not 
belong to any of the categories defined in step 2. Using the spoke model, 
those proteins are considered by their decreasing ranking order and each of 
them is pulled from the interaction network along with its neighbors to 
form a protein complex. Note that each protein can belong to one complex 
only. 
In addition to those five steps, ProRank discards complexes of less than three 
members and merges two complexes if more than 50% of the neighbors of each 
protein belonging to the first complex are in the second complex. Figure 6 shows the 
workflow of the ProRank algorithm. 
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Protein-Protein 
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Protein Complexes 
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Removing unreliable interactions 
 
Filtering 
Identifying bridge, fjord and shore 
proteins 
Protein Ranking 
Ordering proteins by their importance 
in the interaction network 
 
Complex Detection 
Forming complexes based on essential 
proteins and using the spoke model 
 
Post-Processing 
Discarding small complexes and 
merging highly-overlapping ones 
 
Protein Similarity Calculating 
Calculating the similarity scores 
among all proteins 
 
Figure 6: The workflow of the ProRank algorithm which 
takes as input a protein-protein interaction network and 
detects the corresponding protein complexes.  
 
 
Figure 109: Yeast PPI sub-network. The nodes colored in yellow 
correspond to essential proteins identified by the ProRank 
algorithm.Figure 110: The workflow of the ProRank 
algorithm which takes as input a protein-protein interaction 
network and detects the corresponding protein complexes.  
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2.2 Detecting Protein Complexes in Dynamic Protein-Protein Interaction 
Networks 
PPI networks are dynamic in nature (Levy & Pereira-Leal, 2008). In the 
direction of acquiring better complex-detection results, computational methods ought 
to profit from the abundance of biological information provided by advanced 
experimental techniques to model the dynamics of protein interactions. A single 
network is usually used to represent a PPI dataset. In contrast, a dynamic PPI 
network can be visualized by a series of schemes representing snapshots of the 
network states, corresponding to different stages and/or locations of molecular 
activities. We will hereafter highlight some of the potential concepts and approaches 
that can be used to model the dynamics of protein interaction networks. 
Gene expression datasets present quantitative measurements of RNA species 
in cellular compartments across different conditions (Lovén et al., 2012). Genome-
wide expression levels can now be generated (Secrier & Schneider, 2013). Time-
series gene expression data report quantities of RNA species across various time 
points in cellular processes. Genes with correlated expressions across subsets of 
conditions most likely interact. When combined with PPI data to simulate the 
interaction dynamics, they can potentially reveal the processes which underline the 
formation of protein complexes. We note here that not all the genes described in one 
biological dataset may be covered in another dataset. However, combining data from 
multiple sources is viewed as advantageous since it helps overcome data limitations 
such as false-positive and false-negative interactions in PPI datasets and low gene 
coverage in gene expression datasets. For example, PPI and gene expression data 
combination is done in (Wang, Peng, Xiao, Li, & Pan, 2013) where it is shown that a 
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just-in-time mechanism elapsing through continuous time points delineates the 
formation of most protein complexes. The statistical 3-sigma principle is used in 
(Wang, Peng, Xiao, Li, & Pan, 2013) and (Wang, Peng, Li, Luo, & Pan, 2011) to 
define the active time points of proteins based on their gene expression levels and 
thus, to introduce approaches for the identification and refinement of protein 
complexes. The core-attachment composition of complexes is recently considered in 
(Li, Chen, Wang, Wu, & Pan, 2014). Relying on gene expression data, the 
identification of a protein complex is split into two main parts: a static core 
consisting of proteins expressed throughout the whole cell cycle and short-lived 
proteins that form a dynamic attachment. The results of these approaches are better 
than the ones deduced from static networks. Kim et al. (Kim, Han, Choi, & Hwang, 
2014) highlight some of the computational methods used to infer dynamic networks 
from expression data, based on statistical dependence to categorize nodes and/or 
edges as active or not. These methods include: Bayesian networks (Friedman, Linial, 
Nachman, & Pe'er, 2000), relevance networks (Remondini et al., 2005), Markov 
Random Fields (Song, Kolar, & Xing, 2009), ordinary differential equations (Bansal, 
Belcastro, Ambesi‐Impiombato, & Di Bernardo, 2007) and logic-based models 
(Morris, Saez-Rodriguez, Sorger, & Lauffenburger, 2010). 
As it is conditioned by time, the occurrence of a protein interaction is also 
subject to the co-localization of its interacting partners in cellular components (Park 
et al., 2011). In fact, unsuccessful interactions caused by inappropriate protein 
localizations can be pathological. Consequently, subcellular localization annotations 
(de Lichtenberg, Jensen, Brunak, & Bork, 2005) can be also used to model dynamic 
PPI networks based on spatial constraints. Indeed, the formation of protein 
complexes is influenced by the localization settings of proteins as well. As a result, it 
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is certainly beneficial to incorporate the spatial dynamics in the direction of 
improving complex-detection approaches. Various methods aim at studying and 
collecting spatial movements of proteins (Lee, Tan, & Chung, 2010). However, in 
addition to mathematical modeling techniques, methods to appropriately integrate 
spatial protein dynamics in PPI networks are still required. 
Gene ontology annotations (Ashburner et al., 2000) provide information 
about genes across different species. They can potentially infer the dynamic aspect of 
PPI networks (Xu, Lin, & Yang, 2010). As an indicator of interaction probability, 
various weighting schemes are introduced to assign PPI weights based on the 
similarity degrees of gene ontology terms between interacting partners. Among these 
approaches are: SWEMODE (Lubovac, Gamalielsson, & Olsson, 2006), which 
detects communities within PPI networks based on weighted clustering coefficient 
and weighted average nearest-neighbors degree measures; and OIIP (Xu, Lin, & 
Yang, 2010), which identifies protein complexes in PPI networks by assigning node 
and edge weights based on the size of gene annotations. 
By modeling the dynamics of PPI networks, we can potentially: reproduce 
the mechanisms of protein-complex formation; uncover new biological facts about 
complexes; overcome limitations existing in most experimental datasets; categorize 
modules deduced from PPI networks; and finally, increase the accuracy and 
reliability of the detected results. 
2.3 Associating Genes to Diseases 
The identification of the genes and the inter-molecular events leading to the 
formation of diseases remains an essential research area towards the development of 
effective medical treatments. Based on the assumption that genes related to similar 
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disorders tend to be functionally associated (Oti & Brunner, 2007) (Wu, Jiang, 
Zhang, & Li, 2008), existing methods often follow a guilt-by-association (Altshuler, 
Daly, & Kruglyak, 2000) conjecture by which genes are ranked by their similarity to 
known disease genes. We hereafter list various existing approached for gene-disease 
association. 
Deng et al. (Deng, Chen, & Sun, 2004) combine physical and genetic 
interactions of proteins with gene expression networks, protein complex data and 
domain structures to form an integrated probabilistic model to predict protein 
functions. They apply the Markovian random field theory. Xu and Li (Xu & Li, 
2006) classify genes as disease-related or not based on PPI network topology 
features, using the k-nearest neighbor algorithm. Ma et al. (Ma, Lee, Wang, & Sun, 
2007) apply a method based on Markov Random Field (MRF) on a high-throughput 
dataset comprising gene expression profiles and protein interaction data. They seek 
to prioritize disease genes without requiring known candidate genes. Lage et al. 
(Lage et al., 2007) consider that mutations in members of protein complexes lead to 
comparable phenotypes. Accordingly, they build a phenome-interactome network by 
integrating phenotypic data and phenotypic similarities with a high-confidence 
human protein interaction network. They use a Bayesian classifier to potentially link 
previously-unknown protein complexes to diseases. Köhler et al. (Köhler, Bauer, 
Horn, & Robinson, 2008) apply a random walk with restart algorithm (RWR) on a 
heterogeneous interaction network to prioritize candidate disease genes. They 
consider that global network-similarity measures reflect the relationships among 
disease genes better than direct or shortest-paths algorithms. Li and Agarwal (Li & 
Agarwal, 2009) use pathway data to answer the gene prioritization problem. They 
examine disease relationships via literature mining to identify disease genes. That is 
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done by associating diseases to biological pathways where those genes are enriched 
and linked to diseases based on their shared pathways. Zhang et al. (Zhang et al., 
2012) construct a combined classifier on multiple PPI network topology features to 
identify disease genes. Guan et al. (Guan et al., 2012) create tissue-specific 
functional networks to prioritize disease genes. Their approach is based on the notion 
by which tissue-specificity is viewed as an essential factor that highlights the 
diversity of protein roles in different cell lineages. In other words, forming tissue-
specific functional networks can potentially lead to more accurate gene-phenotype 
associations. Li et al. (Li et al., 2014) introduce novel topological attributes and use 
support vector machines (SVM) to classify genes as disease-related or not. Chen et 
al. (Chen B. , Wang, Li, & Wu, 2014) introduce a method based on the Markovian 
random field theory and Bayesian analysis for gene-disease association. They 
combine biological data from multiple sources in order to prioritize disease genes. 
Although most of the existing approaches perform well, their limitations 
mainly reside in requiring initial settings of parameters and thresholds in addition to 
the dependence on a single set of gene features, either topological or biological. 
2.4 Summary 
The literature offers various solutions to the research problem and objectives 
that we address in our work. Nevertheless, the research area remains open thanks to 
the continuously-growing biological knowledge provided by advanced experimental 
techniques. In view of that, we seek to overcome the limitations of the existing 
approaches while developing algorithms that are also enriched by the available 
biological information. Accordingly, the proposed solution for the first objective is 
not bound by the assumption that protein complexes only correspond to dense 
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subgraphs in PPI networks. Complexes may also overlap. In addition, post-
processing steps are introduced to examine and refine the detected entities based on 
their overlapping protein members. In the second objective, we model the dynamic 
aspect of protein interaction networks by incorporating time-series gene expression 
data. The expressions are analyzed using biclustering techniques (Busygin, 
Prokopyev, & Pardalos, 2008) which allow the identification of subsets of co-
regulated genes across subsets of samples. And in analogy to biological facts, by 
using these techniques, a gene can belong to multiple clusters or may not fit in any 
cluster as well. Finally, we present a classification model for the gene-disease 
association problem which is built based on integrated PPI network topology 
attributes and various biological features collected from multiple sources. We believe 
that by combining computationally-conveyed network analysis and experimentally-
generated biological information, the gene-disease association process can be greatly 
enhanced. 
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Chapter 3: Detecting Protein Complexes in Protein-Protein Interaction 
Networks 
 
In this chapter, we present our approach for the detection of protein 
complexes in PPI networks. Section 3.1 revisits some background information of the 
research objective. In section 3.2, our ProRank+ method is introduced. The 
performance of ProRank+ is tested and compared to the performance of existing 
state-of-the-art approaches in section 3.3. The chapter conclusion is in section 3.4. 
3.1 Background 
The importance of this objective originates from the fact that protein 
complexes are key players in most cellular processes (Gavin et al., 2006). Designing 
suitable methods for the detection of protein complexes in protein interaction 
networks continues to be an intriguing area of research. The more complexes we 
identify, the better we can perceive normal as well as abnormal molecular events. 
Given a set of proteins that participate in a process under study and based on the 
interconnections that they exhibit, biologists use advanced experimental techniques 
to identify the corresponding protein complexes. Nevertheless, this procedure is 
often accompanied with extensive time and cost requirements. Computational 
approaches are consequently developed in order to overcome those drawbacks. Their 
goal is to narrow down the required experimental work by pinpointing protein groups 
which presumably correspond to complexes. Among the existing methods, we here 
recall: the Markov Clustering Algorithm (MCL) (Van Dongen, 2001) which uses 
random walks to find cluster structures in PPI networks; the Molecular Complex 
Detection (MCODE) algorithm (Bader & Hogue, 2003) which interprets complexes 
as dense regions grown from highly-weighted vertices; the clustering based on 
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maximal cliques (CMC) method (Liu, Wong, & Chua, 2009); the Affinity 
Propagation (AP) algorithm (Frey & Dueck, 2007) that uses a distance matrix to 
gradually generate high-quality clusters; the Restricted Neighborhood Search 
Clustering (RNSC) algorithm, presented in (King, Pržulj, & Jurisica, 2004) and 
(Pržulj, Wigle, & Jurisica, 2004), which is a cost-based local search algorithm that 
seeks to partition proteins into highly-interconnected subsets; the RRW algorithm 
(Macropol, Can, & Singh, 2009) that uses repeated random walks to exploit the 
structure of PPI networks; CFinder (Adamcsek et al., 2006) which looks for 
overlapping and fully-connected complexes based on the clique percolation method; 
and recently, ClusterONE (Nepusz, Yu, & Paccanaro, 2012) which identifies protein 
complexes through clustering with overlapping neighborhood expansion. Despite the 
good performance of these methods, most of them are restricted by the assumption 
that protein complexes only correspond to dense subgraphs in PPI networks. Thus, 
they are usually unable to detect complexes with few members and/or few 
interconnections.  Our approach for the detection of protein complexes in PPI 
networks is based on the ProRank method (Zaki, Berengueres, & Efimov, 2012a), 
presented in Chapter 2, which is not restrained by the complex-density assumption. 
We consider the network presented in Figure 7 to trace the ProRank algorithm. It is a 
sub-network generated from the yeast PPI dataset at the Mentha interactome browser 
(Calderone, Castagnoli, & Cesareni, 2013), version date 05/01/2014. It corresponds 
to the largest connected portion of the network and includes 235 interactions of 
scores greater than or equal to 0.99. The yellow nodes correspond to the essential 
proteins identified by ProRank and the detected protein complexes are presented in 
Figure 7. 
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3.2 The ProRank+ Method 
Granting that ProRank achieves competitive results when compared to 
previous approaches, it can be further improved. The pruning, filtering, ranking and 
complex-detection steps are certainly requisite. In fact, PPI datasets are usually 
noisy. They have high false-positives (spuriously-detected interactions) and false-
negatives (missing interactions) rates which could negatively affect the detection 
Figure 7: Yeast PPI sub-network. The nodes colored in yellow correspond 
to essential proteins identified by the ProRank algorithm. 
Figure 8: Detected complexes by the ProRank algorithm when 
applied on the PPI network in Figure 7, under the assumption that 
a protein can belong to one complex only.  
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process. Accordingly, it is important to remove the unreliable edges or even detect 
the missing ones using proper computational techniques. Categorizing the proteins 
and forming the detected complexes based on the essential nodes can potentially lead 
to more accurate results. Moreover, ranking the proteins by their importance in the 
network and using the spoke model to form protein complexes are all vital to the 
complex-detection algorithm. Nevertheless, the similarity calculating step can be 
discarded due to its high computational cost and its low effect on the final results 
(Zaki, Berengueres, & Efimov, 2012a). 
Proteins can participate in multiple cellular functions (Hodgkin, 1998). 
Hence, a protein can belong to many complexes. For instance, among the 1189 
proteins contained in the MIPS catalog of protein complexes (Mewes et al., 2006), 
820 proteins (approximately 69%) belong to more than one complex. Similarly, 
among the 1279 complexes covered by the SGD set (Hong et al., 2008), 332 proteins 
(approximately 26%) belong to multiple complexes. Consequently, the detected 
protein complexes are expected to have common members. A detection algorithm 
which accounts for this fact would most likely lead to more accurate results. This is 
the first alteration of ProRank. To do that, we explore the formation of protein 
complexes from various protein seeds by allowing the complexes to overlap. Indeed, 
the number of detected entities would increase but it is then subject to merging or 
deleting entities based on their degrees of overlaps. The complexes detected after 
adding the overlap assumption to ProRank and applying it on the PPI network in 
Figure 7, are shown in Figure 9. 
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Figure 9: Detected complexes by the ProRank algorithm when applied on the 
PPI network in Figure 7, under the assumption that a protein may belong to 
more than one complex. 
 
The results uphold the improvement added by allowing the detected 
complexes to overlap. However, it can be noticed that the amount of overlaps among 
some of the detected complexes is relatively high. This was anticipated. Actually, 
since all essential proteins are now seeds for protein-complex formation, the ones 
that share numerous neighbors will certainly produce highly similar protein 
complexes. In order to overcome this limitation and to further improve the quality of 
the predicted complexes, the following filtering and merging steps are added to the 
algorithm: 
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1- Duplicate complexes resulting from the complex-overlap notion are 
removed. 
2- Next, a merging procedure, Merging by Cohesiveness, is applied to 
explore more variations of the detected complexes. In conformity with the 
initial considerations of the ProRank method, we rely on the key roles of 
the essential proteins in the network to establish the merging process. All 
the detected complexes are matched against each other. Two complexes, 
C1 and C2, whose percentage of overlapping essential proteins is above a 
merging threshold, are merged along with their interconnections to form a 
larger complex C. Then, the process uses the cohesiveness measure 
introduced in (Nepusz, Yu, & Paccanaro, 2012) to assess the quality of the 
resulting complex and its iterative extensions as follows. The cohesiveness 
of a complex C is given by equation (6): 
 𝐶𝑜ℎ𝑒𝑠𝑖𝑣𝑒𝑛𝑒𝑠𝑠(𝐶) =  
𝑤𝑖𝑛(𝐶)
𝑤𝑖𝑛(𝐶) + 𝑤𝑜𝑢𝑡(𝐶) + 𝑝
 (6) 
where win(C) is the sum of the weights of edges that are entirely contained 
in C, wout(C) is the sum of the weights of edges that connect the proteins 
belonging to C to the rest of the network and p is a penalty term reflecting 
PPI uncertainties. This cohesiveness measure was developed to model the 
assumption by which a protein complex is viewed as an entity with 
strongly-interconnected members that is well-separated from the rest of the 
network. The successive steps of our merging procedure aim at refining 
merged complex while increasing their cohesiveness measures. For each 
protein, prot, contained in C: first, the set of its neighbors, Nprot, is formed; 
then, for each neighbor protein nprot in Nprot, the complex C’=C ∪ {nprot} is 
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constructed; and if the cohesiveness of C’ is greater or equal to the 
cohesiveness of C, nprot is added to C. After exploring all the proteins 
initially belonging to C in the same manner, the derived complex is added 
to the final list of detected complexes. The pseudocode of merging two 
complexes, Merge_by_Cohesiveness, is presented next. 
Pseudocode of the Merge-by-Cohesiveness algorithm 
Merge_by_Cohesiveness (C1, C2, merging_threshold) 
ep1 = (set of essential proteins in C1) 
ep2 = (set of essential proteins in C2) 
if size(ep1) > size(ep2) then 
 larger_set = ep1 
else larger_set = ep2 
end if  
ep = ep1 ∪ ep2 
if size(ep) > size(larger_set)*merging_threshold then 
 C = C1 ∪ C2 
 for prot in C do 
 N_prot = (set of neighbors of prot) 
        for n_prot in N_prot do 
 C’ = C ∪ {n_prot} 
                      if Cohesive(C’) ≥ Cohesive(C) then 
                            C = C ∪ {n_prot} 
                      end if 
 end for 
  end for 
end if 
 
3- Additional screening of the generated complexes is applied to remove 
possible duplicates. 
In summary, Figure 10 shows the steps of the ProRank+ algorithm. 
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Figure 10: Steps of the ProRank+ algorithm. 
 
 
3.3 Experimental Study 
3.3.1 Datasets and Evaluation Criteria 
ProRank+ is tested on five large-scale protein-protein interaction datasets 
associated to the well-studied yeast microorganism. Four of the datasets consist of 
weighted protein interactions, they are: Collins (Collins et al., 2007), Krogan core 
and Krogan extended (Krogan et al., 2006), and Gavin (Gavin et al., 2006). The fifth 
dataset, BioGRID (Stark et al., 2006), consists of unweighted interactions. The 
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characteristics of the five datasets used in the experimental work are shown in Table 
1. 
Dataset 
No. of 
Proteins 
No. of 
Interactions 
Network 
Density 
Average no. 
of neighbors 
Collins 1,622 9,074 0.007 11.189 
Krogan Core 2,708 7,123 0.002 5.261 
Krogan extended 3,672 14,317 0.002 7.798 
Gavin 1,855 7,669 0.004 8.268 
BioGRID 5,640 59,748 0.004 21.187 
 
The sets of predicted complexes are matched against the MIPS catalog of 
protein complexes (Mewes et al., 2000). The same datasets and the reference set of 
complexes are used to evaluate the ClusterONE method and to compare its 
performance with other approaches. We also adopt the same quality scores applied in 
(Nepusz, Yu, & Paccanaro, 2012) to assess the quality of our algorithm. In addition, 
it is important to note that the parameters of the compared algorithms are optimized 
in such a way to produce best possible results. Given m predicted complexes and n 
reference complexes and based on the confusion matrix, T = [tij], the quality scores 
cover:  
a. The number of complexes in the reference catalog that are matched 
with at least one of the predicted complexes with an overlap score, w, 
greater than 0.25. The overlap score of two complexes A and B is 
calculated based on equation (7). 
 𝑤(𝐴, 𝐵) =
|𝐴 ∩ 𝐵|2
|𝐴||𝐵|
 (7) 
b. The clustering-wise sensitivity (Sn) which assesses the matching quality 
among the reference complexes and the detected ones. It is calculated 
as shown in equation (8). 
Table 1: Characteristics of the five experimental datasets. 
 
Figure 246: ProRank+ compared to ProRank, MCL, 
MCODE, CMC, AP, ClusterONE, RNSC, RRW, and 
CFinder. Here, the four weighted yeast datasets are used: 
Collins, Krogan core, Krogan extended and Gavin. The 
comparisons are in terms of (a) the number of clusters that 
match the reference complexes, (b) the geometric accuracy 
(Acc) which reflects the clustering-wise sensitivity (Sn) and 
the clustering-wise positive predictive value (PPV), and (c) 
the maximum matching ratio (MMR).Table 38: 
Characteristics of the five experimental datasets. 
 
Figure 247: ProRank+ compared to ProRank, MCL, 
MCODE, CMC, AP, ClusterONE, RNSC, RRW, and 
CFinder. Here, the four weighted yeast datasets are used: 
Collins, Krogan core, Krogan extended and Gavin. The 
comparisons are in terms of (a) the number of clusters that 
match the reference complexes, (b) the geometric accuracy 
(Acc) which reflects the clustering-wise sensitivity (Sn) and 
the clustering-wise positive predictive value (PPV), and (c) 
the maximum matching ratio (MMR). 
 
Figure 248: ProRank+ compared to ProRank, MCL, 
MCODE, AP, ClusterONE, RNSC, and RRW. Here, the un-
weighted BioGRID dataset is used. The comparisons are in 
terms of (a) the number of clusters that match reference 
complexes, and (b) the geometric accuracy (Acc) which 
reflects the clustering-wise sensitivity (Sn) and the clustering-
wise positive predictive value (PPV), and the maximum 
matching ratio (MMR).Figure 249: ProRank+ compared to 
ProRank, MCL, MCODE, CMC, AP, ClusterONE, RNSC, 
RRW, and CFinder. Here, the four weighted yeast datasets 
are used: Collins, Krogan core, Krogan extended and Gavin. 
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 𝑆𝑛 =
∑ 𝑚𝑎𝑥𝑗=1
𝑚 𝑡𝑖𝑗
𝑛
𝑖=1
∑ 𝑛𝑖
𝑛
𝑖=1
 (8) 
c. The clustering-wise positive predictive value (PPV) which also reflects 
the matching quality, mainly in terms of the correctly-matched protein 
members among the detected complexes. It is computed as shown in 
equation (9).  
 𝑃𝑃𝑉 =
∑ 𝑚𝑎𝑥𝑖=1
𝑛 𝑡𝑖𝑗
𝑚
𝑗=1
∑ ∑ 𝑡𝑖𝑗
𝑛
𝑖=1
𝑚
𝑗=1
 (9) 
d. The geometric accuracy (Acc) which is the geometric mean of Sn and 
PPV, as shown in equation (10).  
 𝐴𝑐𝑐 = √𝑆𝑛 × 𝑃𝑃𝑉 (10) 
e. The maximum matching ratio (MMR) which reflects how accurately the 
predicted complexes represent the reference complexes by dividing the 
total weight of the maximum matching by the number of reference 
complexes.  
3.3.2 Experimental Settings of ProRank+ 
The steps of applying ProRank+ on a given dataset, D, and their experimental 
settings are as follows: 
1- Pruning: removing unreliable protein interactions from D using the 
AdjustCD method (Chua et al., 2008). This technique assigns weights to 
the interactions based on the network topology and considers unreliable 
those whose weights are less than a specified threshold. Here, we 
experimentally set the pruning threshold to 0.2 for weighted datasets and 
to 0.45 for unweighted datasets. 
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2- Filtering: identifying bridge, fjord, and shore proteins which could add 
noise to the network, as defined in (Zaki, Berengueres, & Efimov, 2012a). 
3- Protein Ranking: ordering proteins using a ranking algorithm, in analogy 
with the PageRank algorithm. 
4- Complex Detection: considering all the essential proteins, i.e. those that do 
not belong to any of the types defined in step 2, as seeds based on which 
detected complexes are formed using the spoke model. Here, a protein can 
belong to more than one complex. 
5- Pre-processing: filtering the set of predicted complexes by removing 
possible duplicates generated due to the introduced overlap assumption. 
6- Merging by Cohesiveness: two detected complexes, whose overlap is 
above a merging threshold, here 75%, are merged. The subsequent 
complex is iteratively extended following the presented merging 
procedure. 
7- Post-processing: filtering the refined set of predicted complexes to remove 
possibly replicated copies of the same complexes resulting from the 
previous merging step. 
3.3.3 Comparison with Other Methods 
ProRank+ is compared to other state-of-the-art methods. They include 
ProRank (Zaki, Berengueres, & Efimov, 2012a) to highlight the attained 
improvement, Markov Clustering (MCL) (Van Dongen, 2001), the molecular 
complex detection (MCODE) algorithm (Bader & Hogue, 2003), the clustering based 
on maximal cliques (CMC) method (Liu, Wong, & Chua, 2009), the Affinity 
Propagation (AP) algorithm (Frey & Dueck, 2007), ClusterONE (Nepusz, Yu, & 
Paccanaro, 2012), the restricted neighborhood search (RNSC) algorithm (King, 
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Figure 11: ProRank+ compared to ProRank, MCL, MCODE, CMC, AP, 
ClusterONE, RNSC, RRW, and CFinder. Here, the four weighted yeast 
datasets are used: Collins, Krogan core, Krogan extended and Gavin. The 
comparisons are in terms of (a) the number of clusters that match the 
reference complexes, (b) the geometric accuracy (Acc) which reflects the 
clustering-wise sensitivity (Sn) and the clustering-wise positive predictive 
value (PPV), and (c) the maximum matching ratio (MMR). 
 Pržulj, & Jurisica, 2004), the RRW algorithm (Macropol, Can, & Singh, 2009), and 
CFinder (Adamcsek, Palla, Farkas, Derényi, & Vicsek, 2006). The comparisons 
among the results scored by these approaches (Nepusz, Yu, & Paccanaro, 2012) and 
those scored by ProRank + are displayed in Figures 11 and 12. Since not all the 
algorithms can be applied to unweighted datasets, fewer methods for instance were 
applied on the BioGRID dataset. 
The experimental results show that ProRank+ detects a higher number of 
protein complexes that are matched with the reference set. Note that the number of 
clusters predicted by ProRank+ is relatively higher than the number of clusters 
returned by the other methods for Collins, Gavin and BioGRID datasets. 
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Nevertheless, the ratio equivalent to the number of matched complexes over the 
number of detected clusters falls within the same range of the ratio corresponding to 
the other methods. Added to that, ProRank+ achieves higher clustering-wise 
sensitivity (Sn), geometric accuracy (Acc) and maximum matching ratio (MMR) for 
all the considered datasets. However, it cannot surpass the clustering-wise positive 
predictive value (PPV) of ProRank which was the highest for all datasets. This can 
be justified by the fact that PPV tends to be lower when the overlaps among the 
detected complexes are substantial. By the PPV formula, a complex-detection 
algorithm that fully succeeds in detecting the reference complexes has a PPV value 
less than or equals to 1 since there is a matching predicted complex for every 
reference complex, in addition to other predicted complexes that partially overlap 
with reference complexes. On the other hand, a dummy detection algorithm which 
distributes the proteins into separate sets of single elements has a PPV value equals 
to 1, which is greater than the PPV of the perfect algorithm that is able to detect all 
Figure 12: ProRank+ compared to ProRank, MCL, MCODE, AP, 
ClusterONE, RNSC, and RRW. Here, the un-weighted BioGRID 
dataset is used. The comparisons are in terms of (a) the number of 
clusters that match reference complexes, and (b) the geometric 
accuracy (Acc) which reflects the clustering-wise sensitivity (Sn) 
and the clustering-wise positive predictive value (PPV), and the 
maximum matching ratio (MMR). 
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reference complexes. Consequently, PPV values must be carefully analyzed since 
they may not always reflect the competence of a certain method. Moreover, the 
geometric accuracy (Acc) is negatively affected by the predicted complexes that do 
not match any of the reference complexes. This somehow contradicts the initial 
purpose of developing methods for the detection of protein complexes which mainly 
consists of finding previously unknown or undiscovered entities. Accordingly, the 
MMR measure (Nepusz, Yu, & Paccanaro, 2012) is introduced to overcome such 
limitations by dividing the total weight of the maximum matching with the number 
of reference complexes. The MMR values achieved by ProRank+ are in the favor of 
the proposed approach. We hereby note that our approach can also be explored using 
other pruning methods such as the ones introduced in (Zaki, Efimov, & Berengueres, 
2013) and (Kritikos, Moschopoulos, Vazirgiannis, & Kossida, 2011). 
3.3.4 Testing the Ability of ProRank+ to Detect Small Complexes 
Detecting small protein complexes is not a common feature of complex-
detection methods. In fact, it is important to identify such complexes in protein 
interaction networks. For instance, among the 313 protein complexes included in the 
MIPS catalogue (Mewes et al., 2006), 104 complexes consist of 2 or 3 proteins 
(approximately 33 %). Most of the approaches which view protein complexes as 
dense regions in the interaction networks are usually unable to detect complexes of 
small sizes. Hence, we also test the ability of ProRank+ to detect small protein 
complexes. We consider the same yeast datasets that are utilized in the previous 
experiments. The set consisting of the 104 complexes of small sizes in the MIPS 
catalogue (Mewes et al., 2006) is formed and used as a reference set. The datasets are 
filtered by the AdjustCD method with a threshold of 0.2. The corresponding results 
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are shown in Table 2. The table highlights the competency of ProRank+ in detecting 
small protein complexes in terms of the number of matched complexes as well as the 
accuracy (Acc) and the maximum matching ratio (MMR) scores. 
Dataset 
Predicted 
Complexes 
Matched 
Complexes 
Sn Acc MMR 
Collins 428 91 0.875 0.935 0.433 
Krogan Core 229 34 0.667 0.816 0.163 
Krogan Extended 260 78 0.75 0.769 0.217 
Gavin 534 57 0.897 0.947 0.293 
BioGRID 823 78 0.882 0.9 0.351 
 
3.3.5 Testing ProRank+ on Human Protein-Protein Interaction Dataset 
When tested on various datasets, weighted and unweighted, ProRank+ is able 
to detect more complexes than state-of-the-art methods with higher quality scores. 
Indeed, the method could be very helpful for biologists if it is also tested on Human 
interactions and proved valuable in detecting known protein complexes of key roles 
in normal and abnormal cellular functions. Therefore, we apply our method on the 
Human protein interactions dataset in the BioGRID repository (Stark et al., 2006). 
The interactions are unweighted, and thus the pruning threshold was set to 0.45. The 
pruned dataset consists of 3031 interactions. ProRank+ is able to predict 267 protein 
complexes. We then examine the detected entities for potential mappings with 
known protein complexes; some of which are presented in Table 3 and highlighted 
hereafter. 
Detected 
Complex 
Proteins Members of the Detected Complex 
Matching 
Percentage 
CCT micro-
complex 
{CCT3, CCT2, CCT8, CCT6A, CCT4, CCT7, 
CCT5, TCP1} 
100 % 
Table 2: The results of testing ProRank+ on small complexes. 
 
Table 150: Selected complexes detected by ProRank+ when tested 
on human protein-protein interaction dataset.Table 151: The 
results of testing ProRank+ on small complexes. 
 
Table 152: Selected complexes detected by ProRank+ when tested 
on human protein-protein int ra tion dataset. 
 
Figure 373: Snapshots of a hypothetical PPI network, showing its 
dynamics through different temporal, spatial and/or contextual 
setting . Nodes and ges of the same color belong to the same 
protein complex.Table 153: Selected complexes detected by 
ProRank+ when tested on human protein-protein interaction 
dataset.Table 154: The results of testing ProRank+ on small 
complexes. 
 
Table 155: Selected complexes detected by ProRank+ when tested 
on human protein-protein interaction dataset.Table 156: The 
results of testing ProRank+ on small complexes. 
 
Table 157: Selected complexes detected by ProRank+ when tested 
on human protein-protein interaction dataset. 
 
Figure 374: Snapshots of a hypothetical PPI network, showing its 
dynamics through different temporal, spatial and/or contextual 
settings. Nodes and edges of the same color belong to the same 
protein complex.Table 158: Selected complexes detected by 
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Table 3: Selected complexes detected by ProRank+ when tested on human 
protein-protein interaction dataset. 
 
Figure 397: Snapshots of a hypothetical PPI network, showing its dynamics 
through different temporal, spatial and/or contextual settings. Nodes and edges 
of the same color belong to the same protein complex.Table 197: Selected 
complexes detected by ProRank+ when tested on human protein-protein 
interaction dataset. 
 
Figure 398: Snapshots of a hypothetical PPI network, showing its dynamics 
through different temporal, spatial and/or contextual settings. Nodes and edges 
of the same color belong to the same protein complex. 
 
Figure 399: Snapshots of a hypothetical PPI network, showing its dynamics 
through different temporal, spatial and/or contextual settings. Nodes and edges 
of the same color belong to the same protein complex.Table 198: Selected 
complexes detected by ProRank+ when tested on human protein-protein 
interaction dataset. 
Ribosomal 
protein complex 
{RPL32, RPS17, RPSA, RPL10A, RPL12, 
SLC25A5, RPL7, RPL18, RPL15, RPL21, 
RPS6, RPS4X, RPL19, RPL14, RPL4, RPS27L, 
RPS23, RPS26, RPS16, RPL7A, RPS24, RPS13, 
RPS15A, RPS8, RPS3A, FAU, RPL11, RPL6, 
RPL9, RPL5, RPS27, RPL17, RPS2, RPS25, 
RPS20, NOP56, RPS15, RPL23A, RPS10, 
RPL10L, RPLP0P6, RPS28, RPS5, RPS9, 
RPL23, RPL18A, RPS3, RPL37A, RPL31, 
RPL10, RPL8, RPS11, RPL36, RPS19, RPL30, 
RPL24, RPS21, RPL27, RPS12, RPL29, RPS29, 
RPS7, RPL22, RPLP0, RPS14, RPL3, RPLP2, 
RPL27A, RPL13, RPS18, RPS27A} 
81.48 % 
PA700-20S-
PA28 complex 
{PSMD8, PSMB2, PSMC3, PSMC4, PSMA4, 
PSMA1, PSMD1, PSMD7, PSMA2, PSMB6, 
PSMB7, PSMD3, PSMB1, PSMC1, PSMC5, 
PSMC2, PSMB4, PSMA6, PSMD6, PSMD14, 
PSMD12, PSMD11, PSMD13, PSMA7, PSMC6, 
PSMA5, PSMB3, PSMB5, PSMA8, PSMD2} 
83.33 % 
SWItch/Sucrose 
NonFermentable 
(SWI/SNF) 
complex 
{SMARCA4, SMARCC1, ARID1A, SMARCE1, 
SMARCC2, SMARCA2, SMARCB1} 
60 % 
 
1- The CCT micro-complex (Liou & Willison, 1997) hich participates in 
protein folding, assembly and transp rt. It is fully-detected by ProRank+. 
2- The Ribosomal protein complex (Nakao, Yoshihama, & Kenmochi, 2004) 
is detected with a 81.48 % match. Five additional proteins are detected: 
SLC25A5, RPS27L, NOP56, RPL10L, and RPLP0P6. Their association 
with the detected complex may be just noise or, on the contrary, can 
present biologically meaningful information. 
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3- The PA700-20S-PA28 complex (Kopp, Dahlmann, & Kuehn, 2001) is 
detected with a mapping percentage of 83.33%. This complex is a key 
component of the ATP-dependent proteolytic pathway in eukaryotic cells 
and is responsible for the degradation of most cellular proteins. 
4- A recent publication (Shain & Pollack, 2013) confirms that the mutations 
of the SWItch/Sucrose NonFermentable (SWI/SNF) complex are 
ubiquitous in various types of cancer. Accordingly, future research efforts 
will put more focus on this tumor suppressor complex towards better 
understanding of cancer diseases and in the direction of developing more 
effective therapies. The SWI/SNF complex is composed of ten elements 
distributed as follows: (a) SMARCA2 or SMARCA4, two mutually-
exclusive ATPase enzymatic subunits; (b) ARID1A, ARID1B, or PBRM1, 
three mutually-exclusive subunits associated to functional specificity; (c) 
core and accessory subunits including SMARCB1, SMARCC1, 
SMARCC2, SMARCE1, SMARCD1, SMARCD2, or SMARCD3, 
PHF10, DPF1, or DPF2, DPF3, and ACTL6A or ACTL6B. We map the 
composition of SWI/SNF with the set of predicted complexes by 
ProRank+. Our method is able to detect a complex consisting of the 
elements SMARCA4, SMARCC1, ARID1A, SMARCE1, SMARCC2, 
SMARCA2, SMARCB1. In comparison with the known structure of 
SWI/SNF, ProRank+ correctly predicts six members out of ten 
corresponding to 60 % of its subunits with a relatively low number of false 
positives. 
The above experiment affirms the ability of ProRank + to identify significant 
and key protein complexes from protein interaction data. In addition, such outcomes 
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can potentially contain relevant and previously-undiscovered protein complexes or 
unidentified protein members of certain complexes. 
3.4 Conclusion 
ProRank+ is an efficient method for detecting protein complexes in protein-
protein interaction networks. The detection process is mainly centered on a ranking 
algorithm that allows the identification of key proteins based on which the 
corresponding components are formed. It is also tailored by a series of pruning, 
filtering and merging steps, allowing the refinement of the drawn complexes. Unlike 
most approaches, the design of our method is not bound by the sole association of 
protein complexes to dense regions in interaction networks. In addition, ProRank+ 
takes into account possible overlaps among complexes and this is an important 
assumption that reflects biological facts. In contrast with other methods, the 
experimental study underlines the competitive ability of ProRank+ to identify protein 
complexes. The performance of our algorithm is tested on weighted and un-weighted 
datasets and using Human protein interaction data as well. The results greatly favor 
our method. 
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t1 t2 tn 
Figure 13: Snapshots of a hypothetical PPI network, showing its dynamics 
through different temporal, spatial and/or contextual settings. Nodes and edges 
of the same color belong to the same protein complex. 
Chapter 4: Detecting Protein Complexes in Dynamic Protein-Protein 
Interaction Networks 
 
In this chapter we present our solution for the second research objective: 
modeling the dynamic aspect of PPI networks and detecting protein complexes 
accordingly. In section 4.1, we review the motivation of this objective and list the 
advantages of modeling the dynamics of protein interaction networks. The DyCluster 
method is introduced in section 4.2. The experimental study and results are presented 
in section 4.3. Finally, the chapter is concluded in section 4.4. 
4.1 Background 
Early methods developed for the detection of protein complexes usually 
model protein-protein interaction data as a static and all-inclusive network. However, 
protein interactions do not occur at the same time (Macropol, Can, & Singh, 2009), 
i.e. they are subject to various temporal, spatial and contextual settings. Accordingly, 
instead of a single network representation, we would rather be looking at a series of 
snapshots of a PPI network modeled based on either one or a combination of 
conditions, as shown in Figure 13. 
 
44 
 
Novel experimental techniques can currently make such biological 
information available. Hence, the shift from viewing PPI networks as static to 
modeling the dynamics of these networks became fundamental (Przytycka, Singh, & 
Slonim, 2010). Hereafter, we highlight some of the advantages of this transition. 
First, it is a natural response to advances in experimental methods as it enhances the 
replication of real biological events. Indeed, the more representative are the models 
and the methods, the higher the accountability and the accuracy of the produced 
results. Second, by combining different biological data, we can reach a 
computational visualization level of protein interaction events that could verify or 
even contradict biological concepts. Furthermore, previously unknown facts may be 
learned, such as the characterization of hub proteins (Han et al., 2004) as “party 
hubs” which interact with their partners at the same time or “date hubs” which 
connect to their partners at different times and locations. In addition, integrating 
multiple types of biological information allows overcoming data limitation issues. 
For instance, PPI datasets are usually susceptible to high error rates (Reguly et al., 
2006); they may have missing interactions or may include spuriously-detected ones. 
Moreover, possible enrichment data that can be used to model the dynamics of PPI 
networks, such as gene expression profiles (Chen & Yuan, 2006) and gene ontology 
(Xu, Lin, & Yang, 2010), suffer from low gene coverage in contrast with most PPI 
datasets, in which the number of interacting proteins is typically very high (Von 
Mering et al., 2002). The recurrence of information and/or inferences that are drawn 
from different types of biological data can be seen as a confidence indicator. In view 
of that, the integration of various datasets, even if not highly-credible, in the 
direction of modeling PPI dynamics can potentially reduce the effect of false positive 
and false negative rates, as well as low coverage issues. In contrast with static PPI 
45 
 
networks, the information revealed by dynamic networks is at a higher level of 
details. For instance, in the problem of identifying protein complexes, most of the 
presented algorithms do not differentiate between functional modules and protein 
complexes. That is mainly due to the absence of embedded information in the 
networks that could guide the search. In fact, complexes are formed by proteins 
which interconnect at the same time and place, whereas the members of functional 
modules may interact at different times and places (Spirin & Mirny, 2003). 
Accordingly, when PPIs are constrained by spatiotemporal conditions inferred from 
gene expression and gene ontology datasets, for example, the detected components 
could more likely be categorized as protein complexes or functional modules. 
Likewise, dynamic PPI modeling may highly contribute to the detection of protein 
subcomplexes. Various approaches were developed to solve this important research 
problem, but all based on static networks (Zaki & Mora, 2014). As dynamic 
modeling can reveal the mechanisms of protein-complex formation and can thus 
yield better complex-detection approaches, it can also provide the same for the 
detection of subcomplexes. Finally, since dynamic PPI networks better describe 
protein interconnections, they can highly lead to better analytical results. The 
integration of temporal, spatial or contextual biological information with PPI data as 
a means to reproduce the PPI dynamics, can be viewed as clustering based on 
temporal, spatial and/or contextual attributes. Hence, proteins and their interactions 
can be grouped based on the integrated conditions and complex-detection methods 
shall be applied accordingly, indeed with a generalization capability. Consequently, 
the reliability of computational approaches is expected to increase. 
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Based on the listed advantages, the next objective is to model the dynamic 
aspect of PPI networks and then modify our complex-detection algorithm, ProRank+, 
accordingly. Our approach is presented hereafter. 
4.2 The DyCluster Method 
The biological information that could be used to represent dynamic PPI 
networks include, but are not limited to, gene expression data (Lovén et al., 2012) 
which report quantitative measurement of RNA species in cellular compartments 
across various conditions, subcellular localization annotations (de Lichtenberg, 
Jensen, Brunak, & Bork, 2005) which provide spatial positions of elements in 
cellular components; and gene ontology annotations (Ashburner et al., 2000) which 
highlight genes that are present across different species. Time-series gene expression 
data measure quantities of RNA across different time points in cellular processes. 
Genes with correlated expressions across various conditions most likely interact. 
Hence, the combination of time-series gene expression information with PPI data can 
be used to model the dynamics of the PPI networks. For instance, that is done in 
(Wang, Peng, Xiao, Li, & Pan, 2013), (Wang, Peng, Li, Luo, & Pan, 2011), (Li, 
Chen, Wang, Wu, & Pan, 2014) and (Kim, Han, Choi, & Hwang, 2014); as 
elaborated in the literature review (Chapter 3). Our proposed approach, DyCluster, 
requires as input a gene expression dataset and a PPI dataset. It consists of five main 
steps: biclustering gene expression data, extracting biclusters’ PPIs, pruning bicluster 
PPIs, detecting protein complexes and finally, merging and filtering the sets of 
detected protein complexes. An outline of the method is presented in Figure 14. 
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Gene Expression Dataset 
Biclustering Gene Expression 
BC1 BC2 BCk . . . 
Extracting Bicluster PPIs 
BC1_PPI BC2_PPI BCk_PPI . . . 
PPI Dataset 
. . . 
Pruning Bicluster PPIs 
Pruned 
BC1_PPI 
Pruned 
BC2_PPI 
Pruned 
BCk_PPI 
. . . 
Detecting Protein Complexes 
DC1 DC2 DCk . . . 
Merging and Filtering 
Detected Protein Complexes 
Figure 14: An outline of the DyCluster method.  
4.2.1 Biclustering Gene Expression Data 
A gene expression dataset shows the expression levels of a typically large 
number of genes across different environmental conditions, time points, organs, 
species, etc. It is conventionally represented as a matrix in which rows and columns 
correspond to genes and their expression levels at different conditions or samples 
respectively. It is assumed that genes which exhibit similar expression patterns 
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across various conditions can be functionally-related (Baldi & Hatfield, 2002). The 
analysis of these datasets is challenging because they are usually unbalanced, i.e. the 
number of genes is quite larger than the number of conditions (Watson & Berry, 
2009). Various approaches are proposed to analyze expression data and to group 
genes according to their expression patterns; in particular, data mining approaches 
such as classification and clustering. Classification methods require knowing the 
label of the resulting classes in advance, which somehow limits the process of data 
exploration. Nevertheless, several research efforts study the application of such 
supervised techniques on gene expression data (Asyali, Colak, Demirkaya, & Inan, 
2006). Likewise, typical clustering techniques have two drawbacks when applied to 
gene expression data (Jiang, Tang, & Zhang, 2004): first, each gene must be placed 
in a cluster even if its similarity with other cluster members is relatively low; second, 
a gene can belong to one cluster only. Consequently, these techniques cannot account 
for the fact that a large number of genes can exhibit multiple biological functions 
(Hodgkin, 1998), and thus can belong to more than one cluster. Besides, clustering 
spans the whole sample set whereas in reality, the expression levels of a gene cluster 
may be correlated based on a subset of samples. Thanks to the simultaneous two-
dimensional clustering capability which they provide, biclustering techniques present 
better means to explore expression data (Madeira & Oliveira, 2004). In fact, they 
allow the identification of subsets of co-regulated genes across subsets of samples. 
Added to that, in analogy to biological facts, a gene may belong to multiple clusters 
or may not fit in any cluster in some cases. 
A problem formulation of biclustering gene expression data is as follows: Let 
A be an n*m data matrix, representing a gene expression dataset consisting of n 
genes measured across m conditions; aij being a real value corresponding to the 
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expression level of the gene at row i and the condition at column j. The goal is to find 
a set of biclusters BC(I, J); where I is a subsets of genes which exhibit similar 
expression patters across the subset of conditions J. 
We highlight some of the existing biclustering approaches which are also used later 
to evaluate the DyCluster method. Biclustering is first applied on gene expression 
data by Cheng and Church (Cheng & Church, 2000). Their method, CC, consists of a 
greedy search heuristic to form the biclusters, namely the set covering algorithm, and 
uses the Mean Square Residue (MSR) measure to assess the biclusters’ quality based 
on a specified threshold. The MSR of a bicluster BC, of I rows and J columns, 
reflects the degree of coherence between the genes and the conditions which it 
includes. It is calculated based on equation (6) where bcij, bciJ, bcIj and bcIJ represent 
the elements in row i and column j, the row and the column means, and the mean of 
BC, respectively. 
 𝑀𝑆𝑅(𝐵𝐶) =
1
|𝐼||𝐽|
∑ ∑(𝑏𝑐𝑖𝑗 − 𝑏𝑐𝑖𝐽 − 𝑏𝑐𝐼𝑗 + 𝑏𝑐𝐼𝐽)
2
|𝐽|
𝑗=1
|𝐼|
𝑖=1
 (11) 
The lower the MSR, the higher is the bicluster coherence. Correlations among 
genes can be expressed in terms of scaling and shifting patterns. A robustness 
characteristic of a biclustering algorithm, when applied on expression data, is in its 
ability to capture both types of patterns. MSR can only detect shifting 
correspondences among the expression levels of genes (Bozdağ, Kumar, & 
Catalyurek, 2010). Despite that, it is used by several similar approaches and some 
variants of this measure are also introduced to identify the scaling patterns 
(Mukhopadhyay, Maulik, & Bandyopadhyay, 2009). The Order Preserving Sub 
Matrix (OPSM) algorithm (Ben-Dor, Chor, Karp, & Yakhini, 2003) searches for 
large submatrices in which genes have the same linear ordering of the samples. The 
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Iterative Signature Algorithm (ISA) (Bergmann, Ihmels, & Barkai, 2003) uses the 
signature algorithm to identify self-consistent transcriptional modules consisting of 
co-expressed genes and the samples corresponding to them. A comprehensive survey 
of these methods can be found in (Madeira & Oliveira, 2004). 
4.2.2 Extracting Bicluster PPIs 
Given the set of gene biclusters, BC = {BC1(I1, J1), BC2(I2, J2), ...,BCk(Ik, Jk)}, 
the next step consists of finding the interconnections among the members of each 
bicluster based on a specified PPI dataset. The interactions involving elements that 
belong to the set of proteins in each bicluster are extracted. 
4.2.3 Pruning Bicluster PPIs 
PPI datasets are usually noisy (Marto, 2009). As a result, many methods are 
developed to prune PPI data and thus to reduce their levels of false positives and 
false negatives such as (Chua et al., 2008) and (Zaki, Efimov, & Berengueres, 2013). 
Here, we use the PE method introduced by Zaki et al. to assess the reliability of 
protein interactions at the level of generated biclusters and to prune the 
corresponding PPI subsets accordingly. Experiments show that PE-measure is 
efficient as it reduces the level of noise in protein interaction networks by looking for 
subgraphs that are closest to maximal cliques, based on the weighted clustering 
coefficient measures. 
4.2.4 Detecting Protein Complexes 
Successively, a protein-complex detection method is applied on the pruned 
biclusters PPIs, disjointedly on each bicluster. Therefore, several sets of identified 
protein complexes are formed, DC1, DC2, ..., DCk. 
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4.2.5 Merging and Filtering 
Merging and filtering the resultant sets of complexes is crucial to the overall 
accuracy of our approach. However, developing an appropriate post-processing 
method is challenging because it is subject to various considerations. For instance, in 
its simplest form, it may consist of matching the detected entities against each other 
and combining the ones which have an overlap greater than a certain threshold. In 
contrast, keeping the common members of highly-overlapping entities may also be 
explored and it might lead to better outcomes. Another approach may think through 
the core-attachment interpretation of complexes (Gavin et al., 2006) and consider 
that a repeated subgroup of interacting proteins in several detected groupings may be 
a potentially correct core, which forms different complexes when linked with various 
protein attachments. Nonetheless, in our paper, we keep this task for later research 
stages and we hereby limit the formation of the combined set of complexes to 
merging based on an overlap threshold and a condition by which members of one 
complex interact with a certain percentage of members of the other complex; in 
addition to filtering duplicates. This step finalizes the complex-detection process. 
4.3 Experimental Study 
4.3.1 Datasets 
DyCluster requires a gene expression dataset to model the dynamic aspect of 
protein interactions and a PPI dataset from which the interconnections among those 
proteins are extracted. Certainly, the higher the homogeneity of both datasets, 
namely in terms of the species and the number of common genes that they cover, the 
better are the expected outcomes. We refer to Gene Expression Omnibus (GEO) 
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repository (Barrett et al., 2013) from which we select the expression dataset of 
accession number GSE3431 (Tu, Kudlicki, Rowicka, & McKnight, 2005), entitled 
“Logic of the yeast metabolic cycle”. It reports the expression levels of genes across 
twelve time intervals in three successive metabolic cycles. Our choice is primarily 
based on its wide coverage of yeast proteins and potentially, a high number of 
participants in various cellular processes. The yeast PPI dataset is downloaded from 
the Database of Interacting Proteins (DIP) (Xenarios et al., 2002) catalogue of 
experimentally-determined protein interactions. Finally, we compare our results to 
the CYC2008 catalogue (Pu et al., 2009) containing 408 complexes, as reference set 
of yeast protein complexes. 
4.3.2 Evaluation Scores 
The quality scores, used to evaluate our approach, include: (a) the number of 
complexes in the reference catalogue that are matched with at least one of the 
predicted complexes with an overlap score, OS ≥ 0.2; (b) the clustering-wise 
sensitivity (Sn) and (c) the clustering-wise positive predictive value (PPV) used to 
calculate the matching quality, mainly in terms of the correctly-matched protein 
members among the detected complexes; (d) the geometric accuracy (Acc) which is 
the geometric mean of Sn and PPV; and (e) the maximum matching ratio (MMR) 
which measures the maximal one-to-one mapping between predicted and reference 
complexes by dividing the total weight of the maximum matching with the number 
of reference complexes. Note that the same measures are used to evaluate the 
ProRank+ method, introduced in the previous chapter. 
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4.3.3 Algorithms 
For the gene expression biclustering step, we use three algorithms: OPSM 
(Ben-Dor, Chor, Karp, & Yakhini, 2003), CC (Cheng & Church, 2000) and ISA 
(Bergmann, Ihmels, & Barkai, 2003). Here, we note that although efforts are spent in 
the direction of finding suitable ways to evaluate biclustering approaches (Oghabian, 
Kilpinen, Hautaniemi, & Czeizler, 2014), comparing their performances is still a 
challenging task. Added to that, in order to shed the light on the advantage of using 
gene expression data, we also examined the results of applying the framework using 
the one-way clustering method k-means (Hartigan & Wong, 1979), based on 
Pearson’s correlation as a distance measure. The parameters settings of these 
algorithms are presented in Table 4. We used the BicAT tool (Barkow et al., 2006) to 
visualize and perform the biclustering of the gene expression dataset. 
 Parameter Settings 
CC 
upper limit of MSR:  = 0.5 
threshold for multiple node deletion:  = 1.2 
number of output biclusters = 10 
OPSM number of passed models for each iteration: l = 10 
ISA 
threshold of genes: t_g = 0.5 
threshold of chips: t_c = 0.5 
number of starting points = 100 
K-means 
distance measure: Pearson’s correlation 
number of clusters = 10 
number of iterations = 100 
number of replications = 1 
 
For the step consisting of pruning the PPI data at the biclusters levels, we 
apply the PE method (Zaki, Efimov, & Berengueres, 2013) with default parameters, 
specifically, with edges reliability score threshold equals to 0.1. In terms of protein-
complex detection methods, we use ProRank (Zaki, Berengueres, & Efimov, 2012a), 
ProRank+ (Hanna & Zaki, 2014), ClusterONE (Nepusz, Yu, & Paccanaro, 2012) and 
Table 4: Parameter settings of the biclustering algorithms. 
 
Tabl  310: Experi ental results of matching the sets of 
protein complexes, detected by the DyCluster framework, 
against the CYC2008 reference catalogue.Table 311: 
Parameter settings of the biclustering algorithms. 
 
Table 312: Experimental results of matching the sets of 
protein complexes, detected by the DyCluster framework, 
against the CYC2008 reference catalogue. 
 
Table 313: The detected components by the DyCluster 
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CMC (Liu, Wong, & Chua, 2009), MCODE (Bader & Hogue, 2003) and CFinder 
(Adamcsek et al., 2006). ProRank, ProRank+, ClusterONE and CFinder are applied 
with default parameters. For CMC, the overlap and the merging thresholds are set to 
0.75 and 0.5, respectively. For MCODE, degree cutoff, node score cutoff, k-core and 
maximum depth from seed are set to 2, 0.2, 2 and 3, respectively. 
Added to that, the generated sets of detected complexes are examined and 
refined as follows: if two complexes have a number of overlapping members greater 
than 75% of the size of the smaller complex; and if the members of the first complex 
interact with at least 50% of the members of the second complex, then they are 
merged. 
4.3.4 Results 
According to the presented framework, the gene expression dataset, 
GSE3431, is processed by the three biclustering algorithms, OPSM, CC and ISA, 
and by the k-means clustering algorithm, one at a time. The PPIs corresponding to 
the proteins contained in each of the resulting biclusters are extracted from the 
specified yeast PPI dataset and are pruned using PE technique. The protein complex-
detection methods, listed above, are applied on the generated biclusters. Finally, the 
detected sets of complexes are merged, filtered and matched against the CYC2008 
reference catalogue. Table 5 shows the corresponding results in terms of the number 
of matched protein complexes and the number of detected complexes along with the 
corresponding evaluation scores. For comparison purpose, the table also includes the 
results of just applying the detection algorithms on the PPI dataset, excluding the 
gene expression data. 
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Method 
Biclustering 
Algorithm 
No. of 
matched 
complexes 
No. of 
detected 
complexes 
Acc Sn MMR PPV 
P
ro
R
a
n
k
 None 41 230 0.4715 0.3072 0.1032 0.7237 
OPSM 78 335 0.5911 0.4627 0.2103 0.755 
CC 63 252 0.5658 0.4296 0.1804 0.7451 
ISA 71 320 0.564 0.4332 0.195 0.7342 
K-means 71 331 0.556 0.4222 0.1896 0.7322 
P
ro
R
a
n
k
+
 None 46 274 0.4788 0.3371 0.1161 0.6801 
OPSM 81 397 0.5982 0.5116 0.225 0.6995 
CC 65 305 0.5668 0.4724 0.1947 0.6802 
ISA 78 392 0.5677 0.4719 0.2231 0.683 
K-means 78 424 0.5687 0.4782 0.2196 0.6764 
C
lu
st
er
O
N
E
 None 76 365 0.6008 0.511 0.2349 0.7064 
OPSM 89 929 0.6426 0.5758 0.2469 0.7172 
CC 78 578 0.6267 0.5465 0.2036 0.7186 
ISA 87 890 0.6015 0.5506 0.2499 0.6571 
K-means 83 862 0.6153 0.533 0.2334 0.7102 
C
M
C
 
None 114 4292 0.6587 0.6517 0.347 0.6658 
OPSM 100 1207 0.6159 0.5566 0.2903 0.6816 
CC 95 1145 0.5983 0.5264 0.2844 0.6801 
ISA 100 1843 0.6041 0.5518 0.3071 0.6614 
K-means 94 1126 0.6088 0.5542 0.2913 0.6689 
M
co
d
e
 
None 62 168 0.55 0.4271 0.149 0.7082 
OPSM 71 475 0.5695 0.4602 0.1835 0.7049 
CC 60 285 0.545 0.4058 0.1581 0.7321 
ISA 63 315 0.5529 0.4232 0.171 0.7222 
K-means 74 448 0.5658 0.4583 0.1947 0.6986 
C
F
in
d
er
 None 116 6381 0.6143 0.5641 0.3776 0.669 
OPSM 94 2079 0.6187 0.525 0.2925 0.7291 
CC 98 1236 0.5977 0.559 0.3005 0.6391 
ISA 
K-means 
99 2119 0.5738 0.5393 0.3021 0.6104 
99 1352 0.5988 0.5455 0.3098 0.6574 
 
 
 
4.3.5 Case Study 
Next, we test the effectiveness of DyCluster on a network of 140 key genes 
involved in programmed cell death in Rat Apoptosis (RT2 Profiler PCR Array Rat 
Apoptosis, PARN-012A) and inflammation (RT2 Profiler PCR Array Rat 
Table 5: Experimental results of matching the sets of protein complexes, 
detected by the DyCluster framework, against the CYC2008 reference 
catalogue. 
 
Table 389: The detected components by the DyCluster framework when 
applied on the Rattus norvegicus datasets.Table 390: Experimental results of 
matching th  s ts of prot in complexes, detected by the DyCluster framework, 
against the CYC2008 reference catalogue. 
 
Table 391: The detected components by the DyCluster framework when 
applied on the Rattus norvegicus datasets. 
 
Table 392: The topological features of genes and their definitions.Table 393: 
The detected components by the DyCluster framework when applied on the 
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Inflammatory Cytokines and Receptors, PARN-011A). All the 140 genes are 
processed using String 9.1 (http://string-db.org/) (Jensen et al., 2009). String is a 
biological database and web resource of known and predicted protein-protein 
interactions. All the corresponding proteins and their interactions are retrieved and 
the network was built. Once the PPI network including 1413 interactions and 140 
proteins related to the Rattus norvegicus species is build, several enrichment features 
available in String 9.1 (features related to KEGG pathway, Reactome Pathway, 
Molecular function, Pfam domain, InterPro-Domains) are used to generate several 
sub-networks/groups which were then considered as protein complexes. The idea 
here is to see whether DyCluster is capable of detecting such groups of biologically 
related proteins given only the PPI network information. 
In this experiment, the gene expression data set, of accession number 
GSE17384, is downloaded from the GEO (Barrett et al., 2013) repository. It is 
entitled: “Gene expression data from the LEC rat model with naturally occurring and 
oxidative stress induced liver tumorigenesis”. It reports the variations of gene 
expression levels in a stepwise manner from the normal liver condition, to chronic 
oxidative stress-induced hepatitis and liver tumor by time-series microarray analysis. 
In other words, the study involves a comparison between normal liver tissues and 
developed liver tumors at different time points. It can potentially reveal genes which 
participate in the progressive formation of the disease. The OPSM method (Ben-Dor, 
Chor, Karp, & Yakhini, 2003) is used to bicluster the gene expression data since it 
shows a relatively good performance in our experimental study. 
Then, we examine the results for potential matching with the reference 
subnetworks/groups generated using String. Table 6 shows the detected components 
by DyCluster framework, listed by types, along with their matching percentages. The 
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experimental results thus confirm the potential of our approach in detecting and 
understanding protein entities of key roles in normal and abnormal cellular functions. 
 Detected Component Matching 
Percentage 
InterPro-
Domains 
Chemokine receptor family 100% 
G protein-coupled receptor, rhodopsin-like 100% 
GPCR, rhodopsin-like, 7TM 100% 
BLC2 family 83.3% 
BLC2-like 83.3% 
Death effector domain 66.7% 
Interleukin-6 receptor alpha, binding 50% 
Death domain 100% 
Apoptosis regulator, Bcl-2, BH2 motif, conserved site 75% 
Chemokine interleukin-8-like domain 60% 
KEGG 
Pathway 
Chemokine signaling pathway 40% 
Cytokine-cytokine receptor interaction 32.8% 
NOD-like receptor signaling pathway 31.3% 
Apoptosis 34.4% 
Autoimmune thyroid disease 71.4% 
Huntington's disease 66.7% 
Systemic lupus erythematosus 40% 
Asthma 50% 
Intestinal immune network for IgA production 25% 
Cell adhesion molecules 50% 
Pathways in cancer 70% 
Molecular 
Function 
Peptide receptor activity 58.3% 
Receptor activity 52.2% 
Growth factor activity 60% 
C-C chemokine binding 66.7% 
Tumor necrosis factor receptor superfamily binding 40% 
Death effector domain binding 66.7% 
Growth factor binding 50% 
Nucleic acid binding transcription factor activity 75% 
Chemokine activity 77.8% 
Pfam 
Domains 
7 transmembrane receptor, rhodopsin family 100% 
Apoptosis regulator proteins, Bcl-2 family 83.3% 
Death effector domain 66.7% 
Interleukin-6 receptor alpha chain, binding 50% 
Small cytokines (intecrine/chemokine), interleukin-8 like 53.3% 
Death domain 100% 
 Activation of DNA fragmentation factor 66.7% 
Interleukin-1 family precursors are cleaved by caspase-1 100% 
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Reactome 
Pathway 
Downstream TCR signaling 100% 
FasL/CD95L signaling 100% 
Exocytosis of platelet alpha granule contents 100% 
IRAK4 is activated by autophosphorylation 75% 
Beta defensins 66.7% 
TRAIL  signaling 66.7% 
Interleukin-1 processing 75% 
FASL:FAS Receptor Trimer, FADD complex 100% 
4.4 Conclusion 
DyCluster is a framework for the detection of protein complexes in dynamic 
protein interaction networks modeled by incorporating gene expression data, through 
biclustering techniques. It responds to the important shift from interpreting PPI data 
as a single static network to modeling and exploring the dynamic nature of these 
networks. Our approach is tested using several biclustering techniques and various 
protein complex detection methods. As the experimental results show, the 
incorporation of gene expression data in the process of detecting protein complexes 
in dynamic PPI networks is indeed beneficial, in contrast with the detection of 
complexes in static networks. On one hand, it can notably increase the correctness 
and the quality of the results, as it is the case for ProRank, ProRank+ and 
ClusterONE where the numbers of matched complexes, Acc, Sn, PPV and MMR are 
higher. On the other hand, biclustering genes based on their expression patterns can 
significantly reduce the large number of complexes detected by some algorithms, 
such as CMC and CFinder, while not compromising the quality of the outcomes. The 
framework models the dynamic aspect of PPI networks by grouping proteins 
according to the similarities of their expression patterns across subsets of conditions. 
Moreover, it is not restricted by threshold imposition on gene expression levels. As 
Table 6: The detected components by the DyCluster framework when applied on 
the Rattus norvegicus datasets. 
 
Table 460: The topological features of genes and their definitions.Table 461: 
The detected components by the DyCluster framework when applied on the 
Rattus orvegicus dataset . 
 
Table 462: The topological features of genes and their definitions. 
 
Table 463: The topological features of genes and their definitions.Table 464: 
The detected components by the DyCluster framework when applied on the 
Rattus norvegicus datasets. 
 
Table 465: The topological features of genes and their definitions.Table 466: 
The detected components by the DyCluster framework when applied on the 
Rattus norvegicus datasets. 
 
Table 467: The topological features of genes and their definitions. 
 
Table 468: The topological features of genes and their definitions. 
 
Table 469: The topological features of genes and their definitions. 
 
Table 470: The topological features of genes and their definitions.Table 471: 
The detected components by the DyCluster framework when applied on the 
Rattus norvegicus datasets. 
 
Table 472: The topological features of genes and their definitions.Table 473: 
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mentioned earlier, biclustering approaches are better than conventional clustering 
methods when it comes to expression data analysis. Nonetheless, the results attained 
by DyCluster using the k-means clustering algorithm accentuate the improvement 
which can be gained by incorporating gene expression information to model the 
dynamics of PPI interactions and to detect protein complexes in PPI networks 
accordingly. Finally, the produced results in our case study are in favor of the 
DyCluster framework. 
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Chapter 5: Gene-Disease Association through Topological and Biological 
Feature Integration 
 
In this chapter, we present our gene-disease association approach. 
Background information is presented in section 5.1. The building blocks of our 
learning model are discussed in section 5.2. The experimental study is shown in 
section 5.3. A case study in which we apply our approach on the Diabetes Mellitus, 
Type II disease is presented in section 5.4. The chapter is concluded in section 5.5. 
5.1 Background 
The huge amounts of information generated using high-throughput 
experimental techniques continue to motivate the design of suitable methods for 
valuable biological knowledge mining. In particular, the identification of the genes 
and the inter-molecular events leading to the formation of diseases remains essential 
towards the development of effective medical therapies. The association of genes to 
one disorder accelerates the linkage of key players to other diseases. Full insights 
about the formation processes of most diseases are still incomplete. Based on the 
assumption that genes related to similar disorders tend to be functionally associated 
(Oti & Brunner, 2007) (Wu, Jiang, Zhang, & Li, 2008), existing methods often 
follow the notion of guilt-by-association (Altshuler, Daly, & Kruglyak, 2000) by 
which genes are ranked based on their similarity to known disease genes. The 
literature contains numerous approaches designed to link genes to diseases. We 
hereafter recall some of them. Deng et al. (Deng, Chen, & Sun, 2004) build an 
integrated probabilistic model to predict protein functions based on their physical and 
genetic interconnections, in addition to gene expression networks and known protein 
complexes. Xu and Li (Xu & Li, 2006) apply the k-nearest neighbor algorithm to 
61 
 
identify disease-related genes based on PPI network topology features. Ma et al. (Ma, 
Lee, Wang, & Sun, 2007) prioritize disease genes using a method based on Markov 
Random Field (MRF), applied on gene expression profiles and protein interaction 
datasets. Lage et al. (Lage et al., 2007) integrate phenotypic data and phenotypic 
similarities with a high-confidence human protein interaction network and use a 
Bayesian classifier to link previously-unknown protein complexes to diseases. 
Köhler et al. (Köhler, Bauer, Horn, & Robinson, 2008) apply a random walk with 
restart algorithm (RWR) on a heterogeneous interaction network to prioritize 
candidate disease genes. Li and Agarwal (Li & Agarwal, 2009) answer the gene 
prioritization problem by looking for disease relationships via literature mining to 
identify disease genes. Zhang et al. (Zhang, Li, Tai, Li, & Chen, 2012) classify genes 
based on various PPI network topology features. Guan et al. (Guan et al., 2012) 
create tissue-specific functional networks to prioritize disease genes. Li et al. (Li et 
al., 2014) introduce novel topological attributes and use support vector machines 
(SVM) to classify genes as disease-related or not. Chen et al. (Chen B. , Wang, Li, & 
Wu, 2014) combine biological data from multiple sources in order to prioritize 
disease genes; they develop a method based on the Markovian random field theory 
and Bayesian analysis. Many existing approaches have good performance. However, 
they mainly require initial setting of parameters and thresholds in addition to the 
dependence on a single kind of gene features, either topological or biological. 
We present a learning model which classifies genes as disease-related or not, 
based on both topological and biological features. Given a list of genes, the goal is to 
maximize the contrast between disease and non-disease classes. Accordingly, we 
study the topology of the corresponding PPI network to find distinctive positioning 
of genes and we combine biological data from various sources to discover potential 
62 
 
similarities which characterize each class. Our proposed approach scores an area 
under the receiver operating characteristic (ROC) curve of 0.941 when applied using 
the Naïve Bayes classifier on a multiple disease dataset. 
5.2 Gene Features 
Recent advances in experimental technologies, in general, and in next-
generation sequencing, in particular, offer great means for the identification of 
disease-related genes (Mardis, 2008). Large amounts of informative biological data 
can be easily generated nowadays. Nonetheless, fully perceiving various molecular 
processes still requires the assistance of computational techniques for the analysis 
and the integration of heterogeneous data. Based on the characteristics of reference 
disease genes, the goal is to shortlist other genes which could most likely be related 
to diseases, for further experimental explorations. In our study, we develop a model 
to classify genes as disease-related or not according to common PPI network 
topology attributes and various biological features shared by each type. We believe 
that by gathering computationally-conveyed network study and experimentally-
generated biological information, we can enhance the gene-disease association 
process. 
5.2.1 Topological Features 
Mutations in interacting proteins often lead to similar phenotypes. 
Accordingly, PPI networks in which proteins and their interconnections are 
represented as nodes and edges respectively, significantly reflect the functional 
associations among genes (Xu & Li, 2006). Studying PPI networks to extract the 
topological features can greatly expedite gene-disease association tasks. In view of 
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that, given a set of genes to classify, we examine the corresponding PPI network and 
compute the topological features of the nodes, as described in Table 7. 
Topological 
Features 
Description 
Degree Number of edges that are adjacent to a node 
Eccentricity 
The distance from a node to the farthest node from it in 
the network 
Closeness 
Centrality 
The average distance from a node to all other nodes in 
the network 
Betweenness 
Centrality 
The number of times a node appears on shortest paths 
between nodes in the network 
Authority The value of the information stored at a node 
Hub The quality of a node’s links 
Modularity 
Class 
The class reflecting how well a network decomposes 
into modular communities 
PageRank The rank of a node by its importance in the network  
Component 
ID 
The number of connected components to a node in the 
network 
Clustering 
Coefficient 
The completeness of the neighborhood of a node in the 
network 
Number of 
triangles 
The number of connected triangles including a certain 
node 
Eigenvector 
Centrality 
The importance of a node in the network based on its 
connections 
 
5.2.2 Biological Features 
Various experimental observations can be viewed as sources of descriptive 
evidences that could potentially tell apart disease from non-disease genes (Piro & Di 
Cunto, 2012). Hence, the more attributes we include, the larger the potential contrast 
between gene classes. The biological features of genes considered in our study are 
presented hereafter. 
Table 7: The topological features of genes and their definitions. 
 
Table 507: The topological features of genes and their definitions. 
 
Table 508: The topological features of genes and their definitions. 
 
Table 509: The topological features of genes and their definitions. 
 
Table 510: The topological features of genes and their definitions. 
 
Table 511: The topological features of genes and their definitions. 
 
Table 512: The topological features of genes and their definitions. 
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1- Sequence Length: Previous studies show that disease genes tend to have 
longer sequences (Mushegian et a., 1997). In view of that, the number of 
amino acids in the canonical gene sequence is examined. 
2- Gene Ontology (GO) Terms: The GO project (Ashburner et al., 2000) 
provides a set of hierarchically-controlled vocabulary that describes gene 
products in terms of their biological processes, molecular functions and 
cellular components. Biological processes cover the gene molecular events 
related to the functioning of integrated living units including cells, tissues, 
organs, and organisms. Molecular functions delineate the elemental 
activities of a gene product at the molecular level. Cellular components are 
the parts of a cell or its extracellular environment in which the gene 
resides. 
3- Topological Domains: The topology and the compartments of proteins in 
the cell can potentially take part in disease or non-disease gene 
classification (Ibn-Salem et al., 2014). In particular, the topological 
domain information which describes the subcellular compartments where 
each non-membrane region of a membrane-spanning protein is found. 
4- Chain: This feature shows the extent of a polypeptide chain in the mature 
protein following processing. It can also provide an insight on whether a 
protein is related to disease or not (Park & Park, 2015). 
5- Domain: Defined as a specific combination of secondary structures 
organized into a characteristic three-dimensional structure or fold, protein 
domains usually correspond to structural domains which fold 
independently of the rest of the protein chain. 
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6- Protein Family: Under the assumption that proteins belonging to the same 
family share common evolutionary origins and thus exhibit similar 
functions (Wu, Huang, Yeh, & Barker, 2003); we take into account protein 
family groupings in our classification process. 
7- Pathway: Considering the pathways in which genes participate could 
potentially direct the association of genes to diseases. 
5.3 Experimental Study 
5.3.1 Data Sources and Feature Collection 
We refer to the paper by Goh et al. (Goh et al., 2007) to extract the gene-
disease association data which reports 1777 genes linked to 1284 disorders split into 
22 types. This data is originally derived from the Online Mendelian Inheritance in 
Man (OMIM) database (McKusick, 2007). We preprocess the dataset as reported in 
the paper by Chen et al. (Chen B. , Wang, Li, & Wu, 2014), namely, by removing the 
genes related to “multiple”, “unclassified”, “cancer”, “neurological” diseases in 
addition to the disease types of less than 30 gene members. The PPI dataset is 
extracted from the Human Protein Reference Database (HPRD) (Prasad et al., 2009) 
which originally comprises 37039 edges. We use the PE method presented in (Zaki, 
Efimov, & Berengueres, 2013) to assess the reliability of protein interactions and 
clean the PPI data accordingly. As a result, the final learning dataset consists of 9228 
genes out of which 839 are associated to diseases. 
We use Gephi (Bastian, Heymann, & Jacomy, 2009), the interactive 
visualization and exploration platform, to study the PPI network and compute the 
topological features of the genes as listed in Table 7. Next, we consult the Universal 
Protein Resource (UniProt) (UniProt Consortium, 2014) to extract the biological 
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features of the genes. UniProt is a comprehensive resource that captures accurate and 
consistent information on proteins including, but not limited to, accepted biological 
ontologies, classifications and cross-references. Sequence length, chain and domain 
attributes are directly retrieved and added to the learning dataset. Some 
preprocessing is required for the rest of the biological characteristics which are 
multi-valued and comprise a large number of possible descriptions. Accordingly and 
since we are interested in identifying disease genes, we look for distinctive top 
feature values describing them. For instance, we look for the top 25 GO biological 
processes, molecular functions and cellular components associated to disease genes 
in the learning dataset, convert them to Boolean attributes and find the values 
 
 
The same applies for GO molecular functions, GO cellular components, 
Protein Family and Pathway. Protein family information is based on PROSITE 
database of protein domains, families and functional sites (Sigrist et al., 2012). 
Pathway information is based on the Reactome Pathway Database (Croft et al., 
2014). The number of Topological Domains associated to the genes under 
consideration is relatively lower. For this reason, we pick the top 3 domains and 
Genes GO Biological Process 
g1 v1 v2   
g2 v1 v3 v4  
g3 v2   ... 
. .
 .     
 Top 25 GO Biological Processes 
Genes v1 v3 v4 ... 
g1 1 0 0  
g2 1 1 1 ... 
g3 0 0 0  
 
Figure 15: Conversion to Boolean attributes. 
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convert them to Boolean features in the same manner; they are “cytoplasmic”, 
“lumenal” and “extracellular”. In total, we have 9228 genes with 142 features. 
5.3.2 Classification Model and Results 
After assembling the components of our learning dataset, we develop a 
classification model based on the Naïve Bayes classifier (John & Langley, 1995). We 
use the Weka data mining software (Hall et al., 2009). The generated results are 
based on default parameters of the Naïve Bayes classifier with a 10-fold cross-
validation process. Table 8 and Table 9 represent the confusion matrix and the 
classification scores, respectively. The ROC curve is an essential indicator of the 
classification quality (Zweig & Campbell, 1993). It reflects the classifier's ability to 
distinguish between classes by plotting the true positive rate against the false positive 
rate across various thresholds. The ROC curve of our Naïve Bayes classification is 
presented in Figure 16. It corresponds to an area under curve (AUC) of 0.941. 
Classified as 
Non-Disease 
Genes 
Disease 
Genes 
Non-Disease Genes 7858 531 
Disease Genes 149 690 
 
Class Precision Recall F-Measure AUC 
Non-Disease Genes 0.981 0.937 0.959 0.941 
Disease Genes 0.565 0.822 0.67 
 
Table 8: The confusion matrix showing the number 
of correctly-classified and the incorrectly-classified 
instances per class. 
 
Table 522: The classification scores of our gene 
classification model.Table 523: The confusion 
matrix showing the number of correctly-classified 
and the incorrectly-classified instances per class. 
 
Table 524: The classification scores of our gene 
classification model. 
 
Table 525: The classification scores of our gene 
classification model.Table 526: The confusion 
matrix showing the number of correctly-classified 
and the incorrectly-classified instances per class. 
Table 9: The classificatio  scores of our gene classification 
model. 
 
Table 569: The classifi ation scores of our gene classification 
model. 
 
Table 570: The classifi ation scores of our gene classification 
model. 
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We compare the outcome of our approach to the experimental results 
presented in (Chen B. , Wang, Li, & Wu, 2014) in which several disease-gene 
identification methods are applied on the same gene-association dataset. Those 
methods include: IMRF2 (Chen B. , Wang, Li, & Wu, 2014) which uses the theory of 
Markov Random Field (MRF) and Bayesian analysis to integrate data from various 
sources; MRF-Deng (Deng, Chen, & Sun, 2004) which is also based on MRF; the 
Random Walk with Restart (RWR) algorithm (Köhler, Bauer, Horn, & Robinson, 
2008) proposed to identify disease genes by combining multiple PPI networks; and 
the method by Chen et al. (Chen et al., 2011) who define a Data Integration Rank 
(DIR) score to find key information in integrated data. DIR has the best performance 
when compared to previous approaches (Chen et al., 2011). The AUC score 
comparisons are presented in Table 10 and our approach clearly has better disease-
gene association results. 
T
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e 
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False Positive Rate 
Figure 16: The ROC curve of our learning model, it 
corresponds to an AUC score of 0.941. 
69 
 
 IMRF2 MRF-Deng RWR DIR Our Model 
AUC 0.743 0.551 0.676 0.691 0.941 
 
5.4 Case Study: Diabetes Mellitus, Type II disease 
In order to test the performance of our proposed model, we consider the case 
study of the Diabetes Mellitus, Type II disease which is a metabolic disorder marked 
by high blood sugar and a lack of insulin in the body (Chen, Magliano, & Zimmet, 
2012). The occurrence of this disease is continuously growing making it one of the 
major healthcare challenges around the world. We consult the OMIM database 
(McKusick, 2007), and extract the genes associated to the Diabetes Mellitus, Type II 
(OMIM: 125853). Next, in terms of PPI data, we refer to HPRD (Prasad et al., 2009). 
We collect the corresponding topological and biological features of the genes, as 
described in our approach. Consequently, a learning dataset is formed; it consists of 
9166 genes out of which only 23 are related to the Diabetes Mellitus, Type II disease. 
We consistently use a 10-fold cross-validation Naïve Bayes classifier to build the 
model. The resultant confusion matrix is shown in Table 11. It corresponds to an 
AUC score of 0.895. 
Classified as 
Non- Diabetes 
Genes 
 
 
Diabetes 
Genes 
Non-Diabetes Genes 9027  116 
15 Diabetes Genes 8  
 
The attained results are in favor of the presented model which can identify 15 
of the Type II Diabetes genes, equivalent to 65.2%. In comparison, our model has a 
Table 10: AUC score comparison of our model with 
previous approaches. 
 
Table 682: The confusion matrix showing the number of 
correc ly-classified and the incorrectly-classified instance  
per class in our Diabetes Mellitus, Type II case study.Table 
683: AUC score comparison of our model with previous 
approaches. 
 
Table 684: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances 
per class in our Diabetes Mellitus, Type II case study. 
 
Table 685: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances 
per class in our breast cancer case study.Table 686: The 
confusion matrix showing the number of correctly-
classified and the incorrectly-classified instances per class 
in our Diabetes Mellitus, Type II case study.Table 687: 
AUC score c mpa i on of our mod l with previous 
approaches. 
 
Table 688: The confusion matrix showing the number of 
correctly-classified and the i correctly-classified instances 
per class in our Diabetes Mellitus, Type II case study.Table 
689: AUC score comparison of our model with previous 
approaches. 
 
Table 690: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances 
per class in our Diabetes Mellitus, Type II case study. 
 
Table 691: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances 
per class in our breast cancer case study.Table 692: The 
confusion matrix showing the number of correctly-
classified and the incorrectly-classified instances per class 
in our Diabetes Mellitus, Type II case study. 
Table 11: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances 
per class in our Diabetes Mellitus, Type II case study. 
 
Table 762: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances 
per class in our breast cancer case study.Table 763: The 
confusion matrix showing the number of correctly-
classified and the incorrectly-classified instances per class 
in our Diabetes Mellitus, Type II case study. 
 
70 
 
better performance than the method by Chen et al. (Chen, Wu, & Jiang, 2013) which 
predicts 13 Type II Diabetes genes. 
5.5 Conclusion 
Finding suitable methods for the identification of disease genes remains 
essential towards understanding how various disorders are formed and ultimately 
finding appropriate medical treatments. Our solution integrates topological features 
calculated based on PPI network analysis with various biological 
information/features of genes stored in multiple databases. Our experimental work 
verifies our initial hypothesis. By combining computationally-conveyed network 
study and experimentally-generated biological information, we can enhance the 
gene-disease association process. 
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Chapter 6: A Comprehensive Case Study: Breast Cancer 
 
6.1 Background 
In this chapter, we present a comprehensive case study on which we apply the 
approaches introduced in this dissertation. The main question that we would like to 
answer here is: by applying our gene-disease association model on a specific disease 
and given that it is able to reliably-identify the disease-related genes, can our 
complex-detection method, ProRank+, generate substantial groupings of those genes 
from a PPI network? To answer this question, we consider the breast cancer case 
study. This disease develops in breast tissues and it is actually the highest occurring 
cancer type in women worldwide (World Health Organization, 2014). Indeed, it is 
important to identify the key players as well as the cellular events which lead to the 
formation of this malady. We start by validating the reliability of our model in 
identifying the genes related to breast cancer. Once confirmed, we apply the 
ProRank+ algorithm (Hanna & Zaki, Detecting protein complexes in protein 
interaction networks using a ranking algorithm with a refined merging procedure, 
2014) to potentially detect protein clusters that can be associated to breast cancer. 
6.2 Identifying Genes Related to Breast Cancer 
From the OMIM database (McKusick, 2007), we get the list of genes related 
to breast cancer (OMIM: 114480). We refer to the Human Protein Reference 
Database (HPRD) (Prasad et al., 2009) and download the up-to-date Human PPI 
dataset. Then, we compute the topological features and collect the biological 
attributes to form the corresponding learning data. It consists of 9167 genes out of 
which 23 breast cancer genes are covered. We use the Naïve Bayes classifier (John & 
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Langley, 1995) with a 10-fold cross-validation to generate the learning model. The 
resultant confusion matrix is presented in Table 12. 
Classified as 
Non- Breast Cancer 
Genes 
Breast Cancer 
Genes 
Non-Breast Cancer Genes 8973 171 
Breast Cancer Genes 10 13 
 
Although the learning dataset is unbalanced, i.e. the number of disease genes 
is very small in comparison with the number of non-disease genes; our model 
identifies 13 of the breast cancer genes (56.5%). In comparison, the protein complex-
prioritization method by Chen et al. (Chen, Jacquemin, Zhang, & Jiang, 2014) ranks 
6 breast cancer genes in the top ten complexes. Considering the classes unbalance 
and examining the results, we can infer that our model has a relatively good 
performance. 
6.3 Detecting Protein Complexes using ProRank+ 
Considering the performance of our model, we then apply the ProRank+ 
algorithm (Hanna & Zaki, 2014) to potentially detect groupings of breast cancer 
genes in the same PPI network downloaded from HPRD. Various studies noted the 
fact that genes related to the same or similar diseases are often close to one another 
in a PPI network, for example (Oti, Snel, Huynen, & Brunner, 2006) and (Oti & 
Brunner, 2007). In view of that, we refer to the MimMiner (van Driel et a., 2006) 
tool which uses many text-mining algorithms to compute the similarities among 
phenotypes contained in the OMIM database (McKusick, 2007). Given a query 
disease, in our case breast cancer, MimMiner returns the related phenotypes along 
Table 12: The confusion matrix showing the number of correctly-
classified and the incorrectly-classified instances per class in our breast 
cancer case study. 
 
Table 840: Top 24 disorders similar to breast cancer, given by 
MimMiner.Table 841: The confusion matrix showing the number of 
correctly-classified d the i correctly-classified instances per class in 
our breast cancer case study. 
 
Table 842: Top 24 disorders similar to breast cancer, given by 
M mMiner. 
 
Table 843: Groupings of genes associated to breast cancer and similar 
phenotypes, detected by ProRa k+ and numbered by their decreasing 
percentage of disease genes that they contain.Table 844: Top 24 
disorders similar to breast cancer, given by MimMiner.Table 845: The 
confusion matrix showing the number of correctly-classified and the 
incorrectly-classified instances per class in our breast cancer case 
study. 
 
Table 846: Top 24 disorders similar to breast cancer, given by 
MimMiner.Table 847: The confusion matrix showing the number of 
correctly-classified and the incorrectly-classified instances per class in 
our breast cancer case study. 
 
Table 848: Top 24 disorders similar to breast cancer, given by 
MimMiner. 
 
Table 849: Groupings of genes associated to breast cancer and similar 
phenotypes, detected by ProRank+ and numbered by their decreasing 
percentage of disease genes that they contain.Table 850: Top 24 
disorders similar to breast cancer, given by MimMiner. 
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Table 13: Top 24 disorders similar to breast cancer, given by MimMiner. 
 
Table 905: Groupings of genes associated to breast cancer and similar 
phenotypes, detected by ProRank+ and numbered by their decreasing 
percentage of disease genes that they contain.Table 906: Top 24 disorders 
similar to breast cancer, given by MimMiner. 
 
Table 907: Groupings of genes associated to breast cancer and similar 
phenotypes, detected by ProRank+ and numbered by their decreasing 
percentage of disease genes that they contain.Table 908: Top 24 disorders 
similar to breast cancer, given by MimMiner. 
 
with the similarity scores and the causal genes of each phenotype. We select the top 
24 disorders similar to breast cancer and generate the set of associated genes to all of 
them. The considered disorders are listed in Table 13.  
OMIM 
No. 
OMIM Title Similarity 
Score 114480 Breast Cancer 1.0000 
176807 Prostate Cancer 0.5108 
113705 Breast Cancer, Type 1 0.4996 
120435 Colon Cancer, Familial Nonpolyposis, Type 1 0.4560 
155720 Melanoma, Uveal 0.4402 
151623 Li-Fraumeni Syndrome 0.4383 
259500 Osteogenic Sarcoma 0.4205 
278700 Xeroderma Pigmentosum, Complementation Group 
A  
0.4152  
208900 taxia-Telangiectasia  0.4100  
256700 Neuroblastoma  0.4093  
102660 Adamantinoma Of Long Bones  0.4044  
603737 Ovarian Germ Cell Cancer  0.4039  
180200 Retinoblastoma  0.4030  
260350 Pancreatic Carcinoma  0.3909  
300068 Androgen Insensitivity Syndrome  0.3904  
305700 Germinal Cell Aplasia  0.3877  
273300 Testicular Tumors  0.3862  
188550 Thyroid Carcinoma, Papillary  0.3853  
211410 Breast Cancer, Ductal, 1  0.3845  
139300 Gynecomastia, Hereditary  0.3834  
158350 Cowden Disease  0.3822  
210900 Bloom Syndrome  0.3794  
194070 Wilms Tumor 1  0.3783  
211980 Lung Cancer  0.3745  
0.3732  151410 Breakpoint Cluster Region  
 
 
Genes in this set are used as seeds to protein complex-formation by 
ProRank+ when applied on the Human PPI dataset. Note that protein interactions are 
pruned using the PE method (Zaki, Efimov, & Berengueres, 2013). Since we are 
interested in complexes including as much disease genes as possible, we set the 
minimum complex size generated by ProRank+ to 5. The total number of detected 
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complexes is 113. Among those entities, 12 are shortlisted since the percentage of 
disease genes that they include is greater or equal to 30%. Those complexes are 
presented in Table 14, ordered by their decreasing percentage of breast cancer genes. 
Complex 
No. 
Breast Cancer Genes in the Detected Complex 
Percentage of 
Breast Cancer 
Genes 
1 BRCA1, BRCA2, ATM, TP53, RAD51 100% 
2 BRCA1, TP53, MSH2, ATM, CHEK2 83.3% 
3 BRCA1, BRCA2, TP53, RAD51 80% 
4 BRCA1, TP53, MSH2, CHEK2 80% 
5 BRCA1, TP53, XPA, ATM, RAD51, CHEK2 75% 
6 BRCA1, TP53, RB1 60% 
7 
BRCA1, BRCA2, TP53, BARD1, ATM, RB1, AR, 
RAD51, CHEK2 
52.9% 
8 
BRCA1, WT1, BRCA2, TP53, BARD1, ATM, 
PTEN, PPM1D, RAD51, CHEK2, BCR 
37.9% 
9 AR, HIP1, RB1 37.5% 
10 EPHB2, EGFR, BCR 33.3% 
11 BRCA1, EGFR, RB1, PTEN, AR, RNASEL 31.6% 
12 BRCA1, AR, RB1 30% 
 
Figure 17 displays three of those twelve complexes. They respectively 
correspond to complex numbers 8, 7 and 5; based on Table 14. In addition, we show 
the associations of the genes to the phenotypes in which they are involved. 
Table 14: Groupings of genes associated to breast cancer and similar 
phenotypes, detected by ProRank+ and numbered by their decreasing percentage 
of disease genes that they contain. 
 
Figure 540: Detected groupings of proteins as detected by the ProRank+ 
algorithm. Circular nodes correspond to proteins among which the ones 
associated to breast cancer and similar phenotypes are colored. Hexagonal nodes 
correspond to phenotypes given by their OMIM numbers. Interactions among 
the proteins are based on the PPI dataset. Interconnections among phenotypes 
correspond to their similarities based on MimMiner. The dotted lines correspond 
to the association of disease genes to various phenotypes.Table 940: Groupings 
of genes associated to breast cancer and similar phenotypes, detected by 
ProRank+ and numbered by their decreasing percentage of disease genes that 
they contain. 
 
Figure 541: Detected groupings of proteins as detected by the ProRank+ 
algorithm. Circular nodes correspond to proteins among which the ones 
associated to breast cancer and similar phenotypes are colored. Hexagonal nodes 
correspond to phenotypes given by their OMIM numbers. Interactions among 
the proteins are based on the PPI dataset. Interconnections among phenotypes 
correspond to their similarities based on MimMiner. The dotted lines correspond 
to the association of disease genes to various phenotypes.Table 941: Groupings 
of genes associated to breast cancer and similar phenotypes, detected by 
ProRank+ and numbered by their decreasing percentage of disease genes that 
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Figure 17: Detected groupings of proteins as detected by the ProRank+ 
algorithm. Circular nodes correspond to proteins among which the ones 
associated to breast cancer and similar phenotypes are colored. Hexagonal nodes 
correspond to phenotypes given by their OMIM numbers. Interactions among the 
proteins are based on the PPI dataset. Interconnections among phenotypes 
correspond to their similarities based on MimMiner. The dotted lines correspond 
to the association of disease genes to various phenotypes. 
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6.4 Conclusion 
Considering the case of breast cancer, our learning model reliably identifies 
most of the genes related to this disease and the top 24 similar disorders. In view of 
that, we apply the ProRank+ algorithm and successfully detect groupings of those 
disease genes in the PPI network. Out of the 113 complexes generated by ProRank+, 
twelve have more than 30% of their protein members related to breast cancer and 
comparable diseases. Our results support the usability and the reliability of the 
presented solutions in this dissertation. Namely, given a set of proteins reported as 
disease-related, the detected entities by ProRank+ may highly-likely include proteins 
which can also be related to the considered disorders. Therefore, such proteins can be 
subject to further experimental examination. 
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Chapter 7: Conclusion 
 
Looking at a protein-protein interaction network, a reliable computational 
approach can identify proteins and subsequently protein groupings that are possibly 
engaged in certain functions or phenotypes, for further experimental examinations. 
The proposed methodology in this dissertation is divided into three main 
contributions. 
First, we present ProRank+, an effective method for the detection of protein 
complexes in PPI networks. It is based on a ranking algorithm which orders proteins 
by their importance in the network. It also applies a merging procedure to refine the 
detected complexes. In addition, our method accounts for the fact that a protein can 
participate in multiple cellular functions by belonging to several complexes. The 
method is tested on weighted and unweighted yeast datasets, as well as human PPI 
data. When compared to several state-of-the-art approaches, our algorithm is able to 
detect more complexes with better evaluation scores. Additional examinations and 
modeling of biological structures and properties of PPI networks and protein 
complexes could further improve the ProRank+ method.  
Second, since protein interactions are usually subject to various temporal, 
spatial and contextual settings, we introduce a novel way to model the dynamic 
aspect of PPI networks. Genes which exhibit similar expression patterns across 
various conditions most likely interact. Hence, we apply biclustering techniques to 
analyze time-series gene expression data in order to group genes by their expression 
patterns across different subsets of conditions. Then, we detect protein complexes 
according to the generated groupings. In terms of experimental results, our 
framework allows the detection of more protein complexes with higher quality 
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scores. Our approach can be extended by integrating other biological data with PPI 
networks such as gene ontology annotations and subcellular localizations to better 
reproduce the dynamics of protein interaction networks. 
Third, we present a classification model which integrates PPI network 
topology attributes and numerous biological features to identify disease-related 
genes. The experimental results validate our hypothesis that combining 
computationally-conveyed network study and experimentally-generated biological 
information can enhance the gene-disease association process. The approach 
identifies 65.2% of the genes related to the Diabetes Mellitus, Type II disease which 
is a better percentage than existing experiments. Based on the attained results, 
contributions from additional gene features may be examined. Moreover, the 
presented approach can be extended by exploring various diseases and ultimately 
linking the outcomes to drug design. Finally, we present a comprehensive study of 
breast cancer. Our learning model recognizes most of the genes associated to this 
disease and the top 24 related disorders. Then, we apply the ProRank+ algorithm to 
detect groupings of those genes in the PPI network.  
The generated results are in favor of our approaches, they support their 
reliability and usability to analyze protein interaction networks and potentially 
discover previously-unknown biological facts. In terms of future research directions, 
our plan includes: (1) Integrating additional biological data and refining the modeling 
of PPI dynamics towards better detection of protein complexes; (2) Working closer 
to biology to potentially explore specific diseases using our approaches, in the 
direction of identifying and validating the associations of genes and protein 
complexes; (3) Computationally and biologically examining the extent at which 
various attributes used in our approaches influence the association of genes to 
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diseases; (4) Finally, developing comprehensive and flexible tools which allow the 
convenient use of the presented methods in this dissertation. 
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